EurekaMag PDF full texts Chapter 34,110

Leventhal, P.S.; Feldman, E.L. 1996: Tyrosine phosphorylation of focal adhesion kinase and paxillin during insulin-like growth factor-I-stimulated lamellipodial advance. Molecular Biology of the Cell 7(Suppl ): 392A

O'toole, E.A.; Yurko, M.A.; Woodley, D.T. 1996: Tyrosine phosphorylation of focal adhesion proteins is critical for keratinocyte migration on extracellular matrix. Journal of Investigative Medicine 44(7): 401A

Henry, G.; Ives, H.E.; Wilson, E. 1996: Tyrosine phosphorylation of focal adhesion-associated proteins in response to mechanical strain in vascular smooth muscle cells. Journal of the American Society of Nephrology 7(9): 1677

Molloy, C.J.; Fleming, T.P.; Bottaro, D.P.; Cuadrado, A.; Pangelinan, M.; Aaronson, S.A. 1991: Tyrosine phosphorylation of gap by the pdgf beta receptor correlates with the activation of p21 c ras evidence for a direct role of p21 c ras in mitogenic signalling by activated tyrosine kinases. Journal of Cellular Biochemistry Suppl (15 Part F): 232

Au, K.; Soulliere, J.; Gurd, J.W. 1993: Tyrosine phosphorylation of glycoproteins during ischemia in rat hippocampus. Society for Neuroscience Abstracts 19(1-3): 1664

Seshu, J.; Mallavia, L.P. 1998: Tyrosine phosphorylation of host cell proteins by Coxiella burnetii. Abstracts of the General Meeting of the American Society for Microbiology 98: 219

Shen, K.; Novak, R.F.; Brooks, S.C.; Sebolt Leopold, J.; Leopold, W.R. 1998: Tyrosine phosphorylation of human estrogen receptor by Stat1. Proceedings of the American Association for Cancer Research Annual Meeting 39: 407

Feng, L.; Zhou, X.; Omary, M.B.shr 1998: Tyrosine phosphorylation of human keratins 8 and 19 via a p38 kinase-dependent pathway. Molecular Biology of the Cell 9(Suppl ): 164A

Barlati, S.; Paracini, F.; Bellotti, D.; De Petro, G. 1991: Tyrosine phosphorylation of human urokinase-type plasminogen activator. Febs Letters 281(1-2): 137-140

Collares Buzato, C.; Jepson, M.A.; Simmons, N.L.; Hirst, B.H. 1995: Tyrosine phosphorylation of junctional proteins controls paracellular permeability in cultured epithelia. Journal of Physiology (Cambridge) 482P: 32P

Zhang, M.Z.; Mckanna, J.A. 1998: Tyrosine phosphorylation of lipocortin dimer in activated microglia. FASEB Journal 12(4): A450

Baraban, J.M.; Fiore, R.S.; Murphy, T.H. 1991: Tyrosine phosphorylation of map kinase induced by stimulation of pi linked glutamate receptor. Society for Neuroscience Abstracts 17(1-2): 16

Ferris D.K.; Kelvin D.J.; White G.A.; Li C C.; Longo D.L. 1991: Tyrosine phosphorylation of p34 cdc2 in vitro by an associated tyrosine kinase correlation with function. Journal of Cellular Biochemistry Suppl (15 Part B): 172

Turner, C.E. 1991: Tyrosine phosphorylation of paxillin during embryonic development. Journal of Cell Biology 115(3 Part 2): 394A

Wang, Z.L.; Palvalko, F.M.; Gunst, S.J. 1996: Tyrosine phosphorylation of paxillin in CA-depleted canine tracheal smooth muscle strips during stimulation with acetylcholine. Biophysical Journal 70(2 Part 2): A47

Mehta, D.; Pavalko, F.M.; Gunst, S.J. 1996: Tyrosine phosphorylation of paxillin in skinned canine tracheal smooth muscle. Biophysical Journal 70(2 Part 2): A46

Pavalko, F.M.; Wang, Z.L.; Gunst, S.J. 1995: Tyrosine phosphorylation of paxillin is associated with contraction of tracheal smooth muscle. Molecular Biology of the Cell 6(Suppl ): 273A

Burridge, K.; Turner, C.E. 1991: Tyrosine phosphorylation of paxillin is stimulated during cell adhesion to fibronectin. Journal of Cell Biology 115(3 Part 2): 394A

Leventhal, P.S.; Feldman, E.L. 1995: Tyrosine phosphorylation of paxillin precedes neurite outgrowth on laminin. Molecular Biology of the Cell 6(Suppl ): 3A

Kuruvilla, A.; Putcha, G.; Poulos, E.; Shearer, W. 1993: Tyrosine phosphorylation of phospholipase C is essential for its activation by platelet-activating factor in a human B cell line. Journal of Immunology 150(8 Part 2): 168A

Yassin, R.R.; Little, K.M. 1994: Tyrosine phosphorylation of phospholipase C-gamma-1 is an early signaling response of colonic epithelial cells to gastrin. Molecular Biology of the Cell 5(Suppl ): 260A

Liao, F.; Shin, H.S.; Rhee, S.G. 1992: Tyrosine phosphorylation of phospholipase c gamma 1 induced by cross linking of fc gamma ri or fc gamma rii in u937 cells. FASEB Journal 6(1): A369

Liao, F.; Shin, H.S.; Rhee, S.G. 1992: Tyrosine phosphorylation of phospholipase c gamma 1 induced by cross linking of fcr gamma ri or fcgamma rii in u937 cells. Biophysical Journal 61(2 Part 2): A369

Carter, R.H.; Park, D.J.; Rhee, S.G.; Fearon, D.T. 1991: Tyrosine phosphorylation of phospholipase c induced by membrane igm in b lymphocytes. Clinical Research 39(2): 294A

Sillman, A.L.; Yellen Shaw, A.; Coggeshall, M.; Monroe, J.G. 1993: Tyrosine phosphorylation of phospholipases C-gamma-1 and gamma-2 after sIgM stimulation of B lymphocytes is developmentally regulated. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 255

Motto, D.G.; Musci, M.A.; Ross, S.E.; Koretzky, G.A. 1995: Tyrosine phosphorylation of pp36 is required for coupling the T cell antigen receptor with PLC-gamma-1. Arthritis and Rheumatism 38(9 Suppl): S233

Staddon, J.M.; Herrenknecht, K.; Smales, C.; Rubin, L.L. 1994: Tyrosine phosphorylation of protein associated with intercellular junctions. Molecular Biology of the Cell 5(Suppl ): 84A

Denning, M.F.; Dlugosz, A.A.; Cheng, C.; Threadgill, D.W.; Magnuson, T.; Yuspa, S.H. 1996: Tyrosine phosphorylation of protein kinase C delta during calcium-induced keratinocyte differentiation involves activation of epidermal growth factor receptor. Journal of Investigative Dermatology 106(4): 908

Denning, M.F.; Yuspa, S.H. 1994: Tyrosine phosphorylation of protein kinase C sigma in murine keratinocytes expressing an oncogenic ras-Ha gene prevents activation by phorbol esters. Proceedings of the American Association for Cancer Research Annual Meeting 35: 614

Yuo, A.; Yagisawa, M.; Kitagawa, S.; Saeki, K.; Miwa, A.; Togawa, A.; Hirai, H.; Yazaki, Y.; Takaku, F. 1997: Tyrosine phosphorylation of proteins in human monocytes. European Journal of Clinical Investigation 27(Suppl 1): A20

Smith Hall, J.; Bennettt, A.; Peavy, D.E. 1993: Tyrosine phosphorylation of proteins in mouse mammary tumor virus induced adenocarcinoma in strain A/ST mice. FASEB Journal 7(3-4): A145

Ghalayini, A.J.; Nordquist, R.E.; Bell, M.W.; Anderson, R.E. 1996: Tyrosine phosphorylation of rod outer segments in vivo and in vitro Effect of light, vanadate and manganese. IOVS Investigative Ophthalmology and Visual Science 37(3): S808

Bai, C.; Bailey, J.L.; May, R.C. 1993: Tyrosine phosphorylation of skeletal muscle proteins is reduced in uremic rats. Journal of the American Society of Nephrology 4(3): 763

Jarvis, L.J.; Lebien, T.W. 1995: Tyrosine phosphorylation of specific human bone marrow stromal cell proteins following contact with human B cells. Blood 86(10 Suppl 1): 594A

Rosenberger, A.; Meyers, S.A.; Galantino Homer, H.; Kopf, G.S. 1998: Tyrosine phosphorylation of stallion sperm during in vitro capacitation. Biology of Reproduction 58(Suppl 1): 76-77

Ott, V.L.; Rapraeger, A.C. 1998: Tyrosine phosphorylation of syndecan cytoplasmic domains Potential regulation of syndecan binding to CASK and protein 41. Molecular Biology of the Cell 9(Suppl ): 54A

Link, D.C.; Liu, F.; Link, N. 1995: Tyrosine phosphorylation of the G-CSF receptor is necessary for maximal proliferative responses and activation of SHC. Blood 86(10 Suppl 1): 10A

Harp, J.B.; Marrero, M.B. 1997: Tyrosine phosphorylation of the Jak-STAT and focal adhesion pathways during growth factor mediated 3T3-L1 preadipocyte replication. FASEB Journal 11(9): A1166

Tohru, T.; Hisatsune, C.; Umemori, H.; Yamamoto, T. 1998: Tyrosine phosphorylation of the NMDA receptor Mechanism and implication. Neuroscience Research Suppl (22): S44

Sawaya, M.E.; Roth, W.I.; Cohen, B.H. 1992: Tyrosine phosphorylation of the androgen receptor mediates receptor activation in human hair follicles. Journal of Investigative Dermatology 98(4): 604

Mcclelland, P.; March, K.L.; Hathaway, D.R. 1992: Tyrosine phosphorylation of the catalytic subunits of calpains i and ii. Biophysical Journal 61(2 Part 2): A326

Bunke, D.; Monning, U.; Kypta, R.M.; Courtneidge, S.A.; Masters, C.L.; Beyreuther, K.T. 1991: Tyrosine phosphorylation of the cytoplasmic domain of alzheimer protein precursors. Iqbal, K , Et Al (Ed ) Alzheimer's Disease: Basic Mechanisms, Diagnosis And Therapeutic Strategies; Selected Papers From The Second International Conference on Alzheimer's Disease And Related Disorders, Toronto, Ontario, Canada, July 15-20, 1990 Xv+675p John Wiley And Sons, Inc : New York, New York, Usa; Chichester, England, Uk Illus Maps 229-236

Gobert, S.; Dussanter Fourt, I.; Courtois, G.; Lacombe, C.; Gisselbrecht, S.; Mayeux, P. 1994: Tyrosine phosphorylation of the erythropoietin receptor Role for mitogenic signal transduction and phosphatidylinositol 3-kinase activation. Blood 84(10 Suppl 1): 427A

Gould, K.L.; Nurse, P. 1989: Tyrosine phosphorylation of the fission yeast cdc2 positive protein kinase regulates entry into mitosis. Nature (London) 342(6245): 39-45

Greenberg, S.; Chang, P.; Silverstein, S.C. 1993: Tyrosine phosphorylation of the gamma subunit of Fc, receptors and paxillin during Fc receptor-mediated phagocytosis in macrophages. Molecular Biology of the Cell 4(Suppl ): 10A

Swenson, K.I.; Piwnica Worms, H.; Paul, D.L. 1990: Tyrosine phosphorylation of the gap junction protein connexin 43 accounts for the pp60 v src induced inhibition of communication in xenopus oocyte pairs. Journal of Cell Biology 111(5 Part 2): 100A

Mui, A.L F.; Kay, R.J.; Humphries, R.K.; Krystal, G. 1991: Tyrosine phosphorylation of the interleukin 3 receptor signals its own cleavage. Journal of Cellular Biochemistry Suppl (15 Part F): 117

Rondinone, C.M.; Gogg, S.; Smith, U.P. 1997: Tyrosine phosphorylation of the p85 subunit of PI 3-kinase directs targeting Evidence for MAP-kinase association and impaired binding to IRS-1. FASEB Journal 11(9): A1354

Foltz, K.R. 1993: Tyrosine phosphorylation of the sperm receptor at fertilization. American Zoologist 33(5): 100A

Cenciarelli, C.; Hohman, R.; Gusovsky, F.; Weissman, A.M. 1992: Tyrosine phosphorylation of the t cell receptor tcr zeta subunit evidence for a modulating gtp binding protein. Journal of Cellular Biochemistry Suppl (16 Part B): 205

Volker, K.W.; Knull, H.R. 1996: Tyrosine phosphorylation of tubulin by zap-70 modulates interactions with enzymes of glycolysis. FASEB Journal 10(6): A1270

Zhou, Y.; Wang, J.; Levitan, L.B. 1996: Tyrosine phosphorylation of two cloned calcium-dependent potassium channels. Society for Neuroscience Abstracts 22(1-3): 1252

Barlati S.; Paracini F.; Bellotti D.; De Petro G. 1991: Tyrosine phosphorylation of urokinase type plasminogen activator. European Journal of Cancer 27(Suppl 3): S28

Menzel, P.; Hawley, S.H.B.; Holash, J.A.; Pasquale, E.B. 1998: Tyrosine phosphorylation patterns of EPH receptors and ephrin-B1 in the chicken embryonic retina. Society for Neuroscience Abstracts 24(1-2): 534

Vaingankar, S.; Martins Green, M. 1995: Tyrosine phosphorylation plays a key role in activation of 9E3/CEF4 by thrombin. Molecular Biology of the Cell 6(Suppl ): 15A

Beguinot, L.; Helin, K.; Velu, T.J.; Lowy, D.R. 1990: Tyrosine phosphorylation positively regulates the transforming ability of the human egf receptor. Journal of Cellular Biochemistry Suppl (14 Part B): 303

Becker, K.M.; Peters, B.; Magin, T.; Bluemcke, I.; Kaiser, H.W. 1998: Tyrosine phosphorylation prevents localization of ankyrin at sites of cell-cell contact but not binding to Na+/K+-ATPase in human keratinocytes. Molecular Biology of the Cell 9(Suppl ): 269A

Simon, H.U.; Yousefi, S.; Blaser, K. 1995: Tyrosine phosphorylation regulates activation and inhibition of apoptosis in human eosinophils and neutrophils. International Archives of Allergy and Immunology 107(1-3): 338-339

Kinch, M.S.; Burridge, K. 1994: Tyrosine phosphorylation regulates cell-cell and cell-matrix adhesions in ras-transformed human breast epithelial cells. Molecular Biology of the Cell 5(Suppl ): 449A

Humphries, M.J.; Ohm, A.M.; Schaack, J.; Adwan, T.S.; Reyland, M.E. 2008: Tyrosine phosphorylation regulates nuclear translocation of PKC delta. Oncogene 27(21): 3045-3053

Reifel Miller, A.E.; Grinnell, B.W. 1993: Tyrosine phosphorylation regulates the DNA binding activity of a HeLa cell nuclear protein. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 187

Diaz Munoz, M.; Ferrer Montiel, A.V.; Montal, M. 1993: Tyrosine phosphorylation regulates the channel activity of the nicotinic acetylcholine receptor. Biophysical Journal 64(2 Part 2): A343

Carlson, G.; Carver, J.; Erickson, M.; Facchina, S.L.; Verma, A. 1995: Tyrosine phosphorylation serves a protein antioxidant role. Society for Neuroscience Abstracts 21(1-3): 753

Tsygankov, A.Y.; Langdon, W.Y.; Feshchenko, E.A. 1998: Tyrosine phosphorylation sites of c-Cbl in T cells. FASEB Journal 12(5): A937

Morton, C.; Wilkie, N.; Boarder, M.R. 1995: Tyrosine phosphorylation, MAPK and PLD in AIi stimulated mitogenesis. Biochemical Society Transactions 23(3): 426s

Zhang, H.; Haasch, D.; Uchic, M.; Kaszubska, W.; Crosby, S.; Grihalde, N.; Suhar, T.; Janis, R.; Okasinski, G. 1996: Tyrosine phosphorylation, nuclear translocation and DNA binding of STATs upon EPO, TPO or IL3 induction. Blood 88(10 Suppl 1 Part 1-2): 55A

Takeda, H.; Ito, M.; Nagafuchi, A.; Yonemura, S.; Tsukita, S.; Tsukita, S. 1993: Tyrosine phosphorylation-dependent regulation of the assembly and functions of intercellular junctions. Cell Structure and Function 18(6): 648

Harris, M.O.; Steinmann, K.; Schlegel, R. 1990: Tyrosine phosphorylations specific to mitosis in mammalian cells. Journal of Cell Biology 111(5 Part 2): 93A

Lieberman, H.R.; Banderet, L.E.; Shukitt Hale, B. 1990: Tyrosine protects humans from the adverse effects of acute exposure to hypoxia and cold. Society for Neuroscience Abstracts 16(1): 272

Pierre, J.; Piperno, S.; Agbotounou, W.; Mousset, S.; Pierre, M.; Jacquemin Sablon, A. 1993: Tyrosine protein kinase inhibitors. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 239

Aharon, M.; Valid, I.B.; Dvilansky, A.; Nathan, I. 1995: Tyrosine protein kinase inhibitors differentially affect interferon-gamma antiproliferative activities. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 8

Lavelle, F. 1997: Tyrosine protein kinase inhibitors in oncology The end of the beginning?. Bulletin Du Cancer (paris). 84(7): 769-770

Tanguay, D.A.; Mcmanus, B.J.; Rothstein, T.L.; Chiles, T.C. 1994: Tyrosine protein kinase mediates antigen receptor-induced jun-B expression in murine B cells. Journal of Cellular Biochemistry Suppl 1994(18D): 411

Whang, K.U.; Kim, H.J.; Lee, J.H.; Park, J.H.; Lee, J.S.; Kim, Y.K. 1998: Tyrosine protein kinase receptor in human melanocytes. Journal of Dermatological Science 16(Suppl 1): S105

Bolen J.B.; Burkhardt A.L.; Bishop P.; Eiseman E.; Horak I.D.; Li Z H.; Thompson P.A. 1991: Tyrosine protein kinase signal transduction in lymphocytes. Journal of Cellular Biochemistry Suppl (15 Part B): 90

Peri, K.G.; Veillette, A. 1994: Tyrosine protein kinases in T lymphocytes. Chemical Immunology 59: 19-39

Halaban, R. 1991: Tyrosine protein kinases in normal and malignant melanocytes. European Journal of Cancer 27(Suppl 3): S4

Pinto, J.M.B.; Kirby, D.A.; Hottinger, S.; Lown, B. 1990: Tyrosine raises repetitive extrasystole threshold ret in the conscious pig with myocardial infarct. FASEB Journal 4(3): A680

Lieberman, H.R.; Shukitt Hale, B.; Luo, S.; Devine, J.A.; Glenn, J.F. 1992: Tyrosine reduces the adverse effect of hypobaric hypoxia on spatial working memory of the rat. Society for Neuroscience Abstracts 18(1-2): 715

Kobayashi, T.; Winder, A.; Urabe, K.; Brewington, T.; Imokawa, G.; Hearing, V.J. 1993: Tyrosine related protein-1 has a specific catalytic function using 5,6-dihydroxy-indole-2-carboxylic acid as a substrate. Pigment Cell Research 6(4 Part 2): 279-280

Bross, R.; Ball, R.O.; Clarke, J.T.R.; Pencharz, P.B. 1997: Tyrosine requirement in children with PKU determined by indicator amino acid oxidation. FASEB Journal 11(3): A437

Roberts, S.A.; Thorpe, J.M.; Ball, R.O.; Pencharz, P.B. 1998: Tyrosine requirement of adult males at a fixed phenylalanine intake using indicator amino acid oxidation. FASEB Journal 12(5): A860

Shurtleff, D.; Thomas, J.R.; Schrot, J.; Kowalski, K.; Harford, R.; Thornton, M.O.; Shea, P.A.; Malik, M. 1992: Tyrosine reverses a cold-stress-induced memory deficit in humans. Society for Neuroscience Abstracts 18(1-2): 1210

Thomas, J.R.; Shurtleff, D.; Schrot, J.; Moran, R. 1994: Tyrosine reverses cold-stress induced impairment of DRL performance in rats. Society for Neuroscience Abstracts 20(1-2): 1564

Sabba, R.P.; Dean, B.B. 1993: Tyrosine sources in potato differing in blackspot susceptibility. American Potato Journal 70(11): 837

Miyagawa, Y.; Nomoto, Y.; Shiraishi, T.; Kawasaki, M.; Ogino, H.; Hayashi, S.; Yagawa, K. 1992: Tyrosine specific protein kinase participates in the pathogenesis of acute immune complex alveolitis in the rat. American Review of Respiratory Disease 145(4 Part 2): A466

Mermelstein, F.H.; Laskin, D.L.; Sirak, A.A.; Laskin, J.D. 1990: Tyrosine specific protein phosphorylation in polymorphonuclear leukocyte pmn activation. Journal of Cellular Biochemistry Suppl (14 Part B): 279

Berkow, R.L.; Dodson, R.W. 1989: Tyrosine specific protein phosphorylation occurs in activated neutrophils. Pediatric Research 25(4 Part 2): 148A

Moaddel, M.; Farrell, D.H. 1997: Tyrosine sulfation and gammaA/gamma fibrinogen/factor XIII interaction. Blood 90(10 Suppl 1 Pt 1): 465A

Mizui, Y.; Kato, H.; Suzuki, S.; Suzuki, N.; Nagaoka, N.; Suzuki, K.; Hashimoto, A.; Yoshitake, S. 1998: Tyrosine sulfation enhanced the anti-factor Xa activity of a novel antithrombin III chimeric protein. Circulation 98(17): I727

Kjalke, M.; Ezban, M. 1994: Tyrosine sulfation in the C-terminus of the heavy chain of B domain-deleted factor VIII is not required for full activity. British Journal of Haematology 87(Suppl 1): 52

Liu, J.; Louie, S.; Hsu, W.; Yu, K.M.; Nicholas, H.B.; Rosenquist, G.L. 2008: Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease. American Journal of Respiratory Cell and Molecular Biology 38(6): 738-743

Dong, J.F.; Lopez, J.A. 1993: Tyrosine sulfation of GP Ib-alpha does not affect cell surface expression of the GP Ib-IX complex. Blood 82(10 Suppl 1): 73A

Pankovich, J.M.; Jimbow, K. 1990: Tyrosine transport in a human melanotic melanoma cell line. Journal of Investigative Dermatology 94(4): 563

Wiesel, F.A.; Andersson, J.; Wieselgren, I.M.; Blomqvist, G.; Bjerkenstedt, L.; Hagenfeldt, L. 1996: Tyrosine transport in schizophrenia. Schizophrenia Research 18(2-3): 157-158

Kraus, L.M.; Kraus, A.P.Jr 1990: Tyrosine tyr and n carbamoyltyrosine n c tyr in renal failure. FASEB Journal 4(7): A1954

Rahbe, Y.; Delobel, B. 1992: Tyrosine utilization in holometabolous insects Case of a Coleoptera Curculionidae, the rice weevil Sitophilus oryzae L. Memoires de la Societe Royale Belge d'Entomologie 35: 737-742

Skorey, K.I.; Huyer, G. 1991: Tyrosine vanadate affinity chromatography purification of aryl sulfatase. FASEB Journal 5(5): A1197

Sreerama, N.; Powers, M.E.; Manning, M.C.; Goldenberg, D.M.; Woody, R.W. 1998: Tyrosine, phenylalanine and disulfide contributions to the circular dichroism of proteins CD spectra of wild-type and mutant BPTI. Biophysical Journal 74(2 Part 2): A63

Cochran, B.J.; Brown, P.J.; Haddox, M.K. 1994: Tyrosine, threonine and serine phosphorylation of ornithine decarboxylase from transformed RAW264 cell. Proceedings of the American Association for Cancer Research Annual Meeting 35: 543

Valius, M.; Bazenet, C.; Kazlauskas, A. 1993: Tyrosine-1021 and 1009 are phosphorylation sites in the carboxy-terminus of the PDGF receptor beta subunit, and are required for binding of phospholipase C-gamma and a 64 kd protein, respectively. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 243

Malech, H.L.; Huang, C.K.; Renfer, L.; Rotrosen, D. 1993: Tyrosine-324 of p47-phox plays a functional role in cell-free activation of phagocyte NADPH oxidase. Clinical Research 41(2): 323A

Woodcock, J.M.; Bagley, C.J.; Zacharakis, B.; Lopez, A.F. 1996: Tyrosine-421 in the GM-CSF, IL-3 and IL-5 receptor common beta chain is necessary and sufficient for binding and signalling by all three ligands. FASEB Journal 10(6): A1311

Liu, S.Q.; Srivastava, S.K. 1995: Tyrosine-48 is located at sorbinil binding site on aldose reductase. FASEB Journal 9(6): A1477

Kitayama, S.; Mitsuhata, C.; Uhl, G.R.; Dohi, T. 1996: Tyrosine-533 is critical for the function of the rat dopamine transporter. Society for Neuroscience Abstracts 22(1-3): 369

Molden, J.; You, Y.; Longmore, G.; Lai, S.Y.; Goldsmith, M.A. 1996: Tyrosine-containing modules of the erythropoietin receptor exhibit functional redundancy with respect to growth signaling and STAT activation. Molecular Biology of the Cell 7(Suppl ): 354A

Chuang, P.I.; Harlan, J.M. 1996: Tyrosine-containing structural motifs are not necessary in the efficient internalization of human E-selectin in Chinese hamster ovary cells. FASEB Journal 10(3): A623

Ward, A.C.; Hermans, M.H.A.; Smith, L.; Van Aesch, Y.M.; Schelen, A.M.; Antonissen, C.; Touw, I.P. 1998: Tyrosine-dependent and independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor receptor are differentially utilized depending on G-CSF concentration. Blood 92(10 Suppl 1 Part 1-2): 64A

Hoppe, H.C.; Joiner, K.A. 1998: Tyrosine-dependent protein sorting in the protozoan parasite Toxoplasma gondii. Molecular Biology of the Cell 9(Suppl ): 386A

D'ascanio, P.; Arrighi, P.; Pompeiano, O. 1997: Tyrosine-hydroxylase -immunoreactivity of Fos positive locus coeruleus neurons after unilateral labyrinthectomy. Society for Neuroscience Abstracts 23(1-2): 1291

Abu-Ali, S.; Fotovati, A.; Shirasuna, K. 2008: Tyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of head and neck cancers. Molecular Cancer 7: 47

Solomon, D.H.; Critz, S.D.; Wible, B.A.; Brown, A.M.; Schwartz, J.H. 1993: Tyrosine-kinase phosphorylation in response to insulin modulates neuronal voltage-gated K+ channels. Society for Neuroscience Abstracts 19(1-3): 711

Chang, C.F.; Bray, T.; Varughese, K.I.; Whiteley, J.M.; Kiefer, P.M.; Xuong, N.H.; Grimshaw, C.E. 1996: Tyrosine-mediated proton transfer in adenine di-nucleotide requiring reduction, dehydrogenase and epimerase enzymatic activities. FASEB Journal 10(6): A971

Ishida, T.; Ishida, M.; Berk, B.C. 1997: Tyrosine-phosphorylation of p130Cas and paxillin by angiotensin II in vascular smooth muscle cells requires c-Src and RhoA. Circulation 96(8): I45-I46, 10-21/97

Rank, J.M.; Weimer, M.K.; Bloomer, J.R.; Freese, D.K. 1989: Tyrosinemia 1 related elevations of zinc protoporphyrin. Hepatology 10(4): 708

Hasanoglu, A.; Tumer, L.; Vidinlisan, S.; Biberoglu, G. 1997: Tyrosinemia type 1 in monozygotic twins. Journal of Inherited Metabolic Disease 20(Suppl 1): 15

Croffie, J.M.; Gupta, S.K.; Chong, S.K.F.; Fitzgerald, J.F. 1997: Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in absence of other signs of liver failure. Gastroenterology 112(4 Suppl): A869

Van Steirteghem, S.; Goyens, P.; Lerminiaux, C.; Fonteyne, C.P.; Van Denb Berg, I.E.M.; Vamos, E.; De Laet, M.H.; Abramowicz, M.J. 1997: Tyrosinemia type I and Hirschsprung disease in a newborn. Journal of Inherited Metabolic Disease 20(Suppl 1): 15

Dionisi Vici, C.; Boglino, C.; Marcellini, M.; De Sio, L.; Inserra, A.; Cotugno, G.; Sabetta, G.; Donfrancesco, A. 1997: Tyrosinemia type I with early metastatic hepatocellular carcinoma Combined treatment with NTBC, chemotherapy and surgical mass removal. Journal of Inherited Metabolic Disease 20(Suppl 1): 3

Rabut, G.; Konner, J.A.; Dragic, T. 1998: Tyrosines 14 and 16 in CCR-5 are necessary for infection by macrophage-trophic HIV-1. Journal of Investigative Medicine 46(1): 142A

Holtzer, M.E.; Adams, K.; Lovett, E.G.; Holtzer, A. 1996: Tyrosines in two-stranded coiled coils are CD active near 280 nm even in the absence of interhelix tyrosine-tyrosine interactions. Biopolymers 38(5): 669-671

Pitzele, B.S.; Chandrakumar, N.S.; Contreras, P.C.; Allen, S.E.; Clare, M.; Savage, M.A.; Hammond, D.L.; Nevins, M.E.; Nash, S.A. 1992: Tyrosyl amides as ligands at the phencyclidine receptor located on the NMDA-sensitive glutamate site. Society for Neuroscience Abstracts 18(1-2): 1510

Willis, K.J.; Szabo, A.G. 1989: Tyrosyl and tryptophyl emission from subtilisins. Biophysical Journal 55(2 Part 2): 516A

Hansen, D.W.Jr; Chandrakumar, N.S.; Husa, R.K.; Peterson, K.B.; Tsymbalov, S.; Stapelfeld, A.; Williamson, L.N.; Reichman, M.; Beardsley, P.M. 1992: Tyrosyl diamides as potent mu and delta opioid receptor ligands. Society for Neuroscience Abstracts 18(1-2): 687

Carlesso, N.; Frank, D.A.; Griffin, J.D. 1995: Tyrosyl phosphorylation and DNA binding activity of stat proteins in hematopoietic cells transformed by p210 BCR/ABL. Blood 86(10 Suppl 1): 264A

Nel, A.E.; Ledbetter, J.A.; Pollack, S. 1990: Tyrosyl phosphorylation of lymphoid map 2 kinase reveals the dual function of cd4 in cd3 induced t cell activation. FASEB Journal 4(7): A2018

Savenkova, M.I.; Francis, G.A.; Heinecke, J.W. 1993: Tyrosyl radical generated by myeloperoxidase initiates low density lipoprotein lipid peroxidation. Circulation 88(4 Part 2): I179

Ramsell, K.D.; Watts, S.W.; Matesic, D.F.; Cobbett, P. 1996: Tyrosyl-phosphorylation is associated with morphological plasticity of RG-2 astroglial cells. Society for Neuroscience Abstracts 22(1-3): 376

Francis, G.A.; Oram, J.F.; Heinecke, J.W.; Bierman, E.L. 1994: Tyrosylated high density lipoprotein enhances cellular cholesterol excretion by a mechanism independent of passive sterol desorption. Circulation 90(4 Part 2): I241

Sane, D.C.; Baker, M.S. 1992: Tyrosylprotein sulfotransferase activity in human platelets. Circulation 86(4 Suppl 1): I151

Sundaram, P.; Slomiany, B.L.; Slomiany, A.; Kasinathan, C. 1991: Tyrosylprotein sulfotransferase in rat gastric mucosa. Journal of Cell Biology 115(3 Part 2): 59A

Bright, J.J.; Sriram, S. 1998: Tyrphostin A1 and B42 prevent EAE by inhibiting IL-12 induced activation of Jak-Stat pathway in T cells. FASEB Journal 12(4): A265

Pai, R.; Ohta, M.; Itani, R.M.; Sarfeh, I.J.; Tarnawski, A. 1997: Tyrphostin A46 inhibits healing of experimental gastric ulcer Evidence for the crucial role of EGF and MAP kinases in the healing process. Gastroenterology 112(4 Suppl): A250

Wang, L.; Kirken, R.A.; Erwin, R.A.; Taub, D.; Murphy, W.J.; Farrar, W.L. 1998: Tyrphostin AG-490 inhibits the JAK3/STAT5a/b signaling pathway and antigen-specific activation of human T cells. FASEB Journal 12(8): A1412

Liang, B.C.; Ullyatt, E. 1998: Tyrphostin AG17 chemosensitizes glioblastoma cells to BCNU by a mitochondrially mediated mechanism. Neurology 50(4 Suppl 4): A273-A274

Kaur, G.; Sausville, E.A. 1994: Tyrphostin AG957 inhibits p210-bcr-abl in K562 chronic myelogenous leukemia cells. Proceedings of the American Association for Cancer Research Annual Meeting 35: 446

Kaur, G.; Sausville, E.A. 1995: Tyrphostin AG957 inhibits shc tyrosine phosphorylation in K562 chronic myelogenous leukemia cells. Proceedings of the American Association for Cancer Research Annual Meeting 36: 437

Fishbein, I.; Banai, S.; Moscovitz, D.; Gertz, S.D.; Gazit, A.; Wolf, Y.; Levitzki, A.; Golomb, G. 1996: Tyrphostin delivery systems for the treatment of restenosis. Pharmaceutical Research (New York) 13(9 Suppl): S253

Warburton, D.; Shun, L.; Bringas, P.; Buckley, S.; Seth, R.; Slavkin, H.C. 1990: Tyrphostin egf receptor kinase inhibitor inhibits early mouse embryo lung branching morphogenesis. Journal of Cell Biology 111(5 Part 2): 241A

Kaur, G.; Gazit, A.; Levitzki, A.; Stowe, E.; Cooney, D.A.; Sausville, E.A. 1994: Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia. Anti-Cancer Drugs 5(2): 213-222

Meydan, N.; Loubser, M.; Cohen, A.; Dadi, H.; Freedman, M.; Grunberger, T.; Roifman, C.M. 1994: Tyrphostin inhibits PRE-B acute lymphoblastic leukemia cell growth. FASEB Journal 8(4-5): A773

Matsumoto, K.; Zhou, D.F.H.; Schleimer, R.P.; Bochner, B.S. 1995: Tyrphostin reduces alpha-4 integrin function in human eosinophils and Jurkat cells. FASEB Journal 9(3): A226

Hauge, D.E.; Aaronson, P.I.; Ward, J.P.T. 1998: Tyrphostin-23 inhibits hypoxic contraction in rat pulmonary arteries. Journal of Vascular Research 35(Suppl 1): 19

Levitzki, A.; Gazit, A.; Vardy, D.; Klaus, S.; Ben Bassat, H. 1992: Tyrphostins as blockers of the proliferation of psoriatic keratinocytes. Abstracts of Papers American Chemical Society 204(1-2): MEDI 6

Levitzki, A.; Gilon, C. 1991: Tyrphostins as molecular tools and potential antiproliferative drugs. Trends in Pharmacological Sciences 12(5): 171-174

Lamb, D.J.; Shubhada, S. 1993: Tyrphostins inhibit Sertoli cell-secreted growth factor stimulation of A431 cell growth. Recent Progress in Hormone Research 48: 511-516

Bilder, G.E.; Krawiec, J.A.; Zilberstein, A.; Levitzki, A.; Perrone, M.H.; Schreiber, A.B. 1990: Tyrphostins inhibit pdgf induced dna synthesis tyrosine specific protein kinase activity and c fos messenger rna expression in vascular smooth muscle cells vsmc. Circulation 82(4 Suppl 3): III571

Romer, L.H.; Burridge, K. 1993: Tyrphostins inhibit pp125-FAK kinase activity in vitro during integrin-mediated adhesion of human vascular endothelial cells. Clinical Research 41(2): 262A

Buhl, A.; Gadwood, R.; Waldon, D.; Kamdar, B.; Groppi, V. 1990: Tyrphostins inhibit the growth of keratinocytes and the effects of minoxidil on mouse vibrissae in culture. Journal of Investigative Dermatology 94(4): 511

Kaebisch, A.; Seay, U.; Lohmeyer, J.; Pralle, H.; Levitzki, A. 1995: Tyrphostins inhibit tyrosine-autophosphorylation of p210-BCR-ABL in vivo and reduce Philadelphia-positive clonogenic cells from CML patients. Onkologie 18(Suppl 2): 149

Baran, D.; Vendeville, B.; Luu, T. 1993: Tyrphostins reversibly inhibit PDGF and bFGF driven murine mesangial cell proliferation. Journal of the American Society of Nephrology 4(3): 594

Palumbo, G.A.; Gazit, A.; Yarom, N.; Levitzki, A.; Ben Yehuda, D. 1994: Tyrphostins, a class of tyrosine kinase inhibitors, induce in vitro apoptosis and cell growth arrest in NHL. Blood 84(10 Suppl 1): 296A

Golomb, G.; Fishbein, I. 1997: Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis. Advanced Drug Delivery Reviews 24(1): 53-62

Sklan, E.; Segal, A.; Priel, E. 1997: Tyrphostins, protein tyrosine kinase blockers, as topoisomerase I inhibitors and anti-cancer drugs. International Journal of Oncology 11(Suppl ): 927

Varga, J. 1996: Tyrrell report on transmissible spongiform encephalopathies A summary of present knowledge and research. Magyar Allatorvosok Lapja 51(1): 48-52

Kindler, P.; Davaud, E.; Strasser, A. 1997: Tyrrhenian coastal deposits from Sardinia A petrographic record of high sea levels and shifting climate belts during the last interglacial. Palaeogeography Palaeoclimatology Palaeoecology 133(1-2): 1-25

Zei, M. 1993: Tyrrhenian sea deposits of the Pontina area A submarine deposit of Strombus on the seabed east of the Circeo Cape. Giornale di Geologia 54(2): 127-141

Giusti, F.; Manganelli, G. 1992: Tyrrheniellina, new name for Thyrrheniella Giusti and Manganelli, 1989. Bollettino Malacologico 28(5-12): 231

Tyryshkin, L.G.; Kolesova, M.A. 2008: Tyryshkin L G, Kolesova M A Assembling the set samples for the differentiation of leaf rust casual agent populations Puccinia recondita f sp Tauschii. Mikologiya i Fitopatologiya 42(1): 78-81

Dunn, T.C. 1994: Tyta luctuosa , the four spotted , new to Co Durham. Entomologist's Record and Journal of Variation 106(11-12): 254

Marti, C.D. 1992: Tyto alba Barn owl. Birds of North America 1992(8): 1-15

Domashevskii, S.V. 1993: Tyto alba in the Crimea. Vestnik Zoologii 1993(4): 55

Lainson, R.; Paperna, I. 1994: Tyzzeria boae n sp, , a new coccidium from the kidney of the snake Boa constrictor constrictor. Memorias do Instituto Oswaldo Cruz Rio de Janeiro 89(4): 523-530

Simpson,V.R.; Hargreaves,J.; Birtles,R.J.; Marsden,H.; Williams,D.L. 2008: Tyzzers disease in a Eurasian otter in Scotland. Veterinary Record 3(18): 539-543

Shirakawa, T.; Maruyama, K.; Nakamura, N.; Awakura, T.; Ohishi, H.; Senba, H.; Higuchi, T.; Sonoda, K.; Ono, T.; Matsui, T. 1989: Tyzzer's disease in a foal. Nihon Juigaku Zasshi. Japanese Journal of Veterinary Science 51(2): 444-446

Ochoterena Booth, H.; Flores Olvera, H. 1992: Tzontzapotl Licania platypus , a resource of economic potential utilized since prehispanic Mexico. Boletin de la Sociedad Botanica de Mexico 1992(52): 115-120

Rice, P.J.; Huang, N.; Abraham, S.T.; Bauman, R.J. 1992: U 0521 decreases contractile responses in rat vas deferens. FASEB Journal 6(4): A1023

Rettenmaier, L.J.; Sharp, G.C.; Takeda, Y.; Luger, A.C.; Hoffman, R.W. 1989: U 1 68kd positive mixed connective tissue disease mctd appears genetically distinct within hla from systemic lupus erythematosus sle. Arthritis and Rheumatism 32(4 Suppl): S39

Cipkus Dubray, L.; Swirtz, M.; Khan, S.; Humphrey, S.; Skaletzky, L.; Meisheri, K. 1992: U 37883a a structurally novel antagonist of the vascular potassium a t p openers. FASEB Journal 6(5): A1777

Gibson, J.K.; Holzgrefe, H.H.; Buchanan, L.V. 1989: U 4006f enhances function recovery and prevents diastolic wall thickening following reperfusion of stunned canine myocardium. Journal of Molecular and Cellular Cardiology 21(Suppl 2): S162

Rogers, H.; Hayes, A.G. 1989: U 50488 h decreases kainic acid induced neurotoxicity in the hippocampal ca3 ca4 region of the rat. British Journal of Pharmacology 96(Suppl): 320P

Qu Z.X.; Xu J.; Perot P.L.; Hogan E.J. 1991: U 50488h reduces vascular permeability and edema in rat spinal cord injury. Society for Neuroscience Abstracts 17(1-2): 163

Althaus, J.S.; Von Voigtlander, P.F. 1989: U 54494a selectively protects against kainate toxicity in rat cerebellar granular cells. Society for Neuroscience Abstracts 15(1): 771

Szmuszkovicz J.; Lahti R.A.; Vonvoigtlander P.F.; Tang A.H.; Althaus J.S.; Lum J.T.; Hoffmann W.E.; Evans D.L.; Franklin S.R.; Et Al 1989: U 67413b a dihydrophenalene 5 ht1a agonist with weak dopamine agonist properties. Society for Neuroscience Abstracts 15(2): 1234

Lahti, R.A.; Piercey, M.F.; Evans, D.L.; Carrigan, K.J.; Neff, G.L.; Barsuhn, C.; Vogelsang, G. 1989: U 68553b a novel dopamine autoreceptor agonist with chronic activity. Society for Neuroscience Abstracts 15(1): 270

Shalinsky, D.R.; Sampson, K.E.; Abraham, I.A.; Howell, S.B. 1992: U 73975 inhibits azidopine labelling of p glycoprotein and selectively enhances vinblastine accumulation in multidrug resistant kb grc1 tumor cells. FASEB Journal 6(4): A1280

Holzgrefe, H.H.; Gibson, J.K. 1989: U 74006f a potent inhibitor of lipid peroxidation enhances recovery of function in stunned canine myocardium. Circulation 80(4 Suppl 2): II241

Malaker, K.; Das, R.M.; Sutherland, G.; Peeling, J. 1991: U 74006f a promising new radioprotective agent. Clinical and Investigative Medicine 14(4 Suppl): A109

Carrea, F.P.; Lesnefsky, E.J.; Horwitz, L.D. 1991: U 74006f decreases necrosis and enhances functional recovery after ischemia reperfusion in isolated rabbit hearts. Journal of the American College of Cardiology 17(2 Suppl A): 228A

Xue D.; Bruederlin B.; Heinicke E.; Li H.; Silvka A.; Buchan A.M. 1990: U 74006f reduced neocortical infarction but does not attenuate selective hippocampal ca1 necrosis. Stroke 21(1): 178

Schreur, P.J.K.D.; Nichols, N.F.; Pregenzer, J.F.; Oostveen, J.A. 1990: U 78875 a benzodiazepine antagonist with anxiolytic properties in rats and mice. Society for Neuroscience Abstracts 16(2): 1322

Piercey, M.F.; Moon, M.W.; Lahti, R.A.; Hoffmann, W.E.; Lum, J.T. 1991: U 86170f a potent dopaminergic agonist that does not induce tolerance with chronic administration. Society for Neuroscience Abstracts 17(1-2): 1348

Pilatte, Y.; Greffard, A.; Terzidis Trabelsi, H.; Bignon, J.; Lambre, C. 1992: U 937 cells are able to release a sialidase activity. FASEB Journal 6(5): A1615

Tobin, P.S. 1997: U S Environmental Protection Agency applications for Acute Exposure Guideline Levels. Abstracts of Papers American Chemical Society 214(1-2): CHAS 14

Schroder, L.J.; Beetem, W.A.; Claassen, H.C.; Emerson, R.L. 1973: U S Geological Survey, Denver, Colorado radiocarbon dates I. Radiocarbon 15(3): 469-478

Goosby, E.P.; Baitty, R.; Eichler, A.; Gomez, M.; Bowen, G.S.ephen 1993: U S government funding to improve access to HIV care for underserved urban populations Year two of the Ryan White Care Act. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 937

Boyce, J.W.; Hodges, K.V. 2005: U and Th zoning in Cerro de Mercado Durango, Mexico fluorapatite; insights regarding the impact of recoil redistribution of radiogenic super 4 He on U-Th/ He thermochronology. Chemical Geology 219(1-4): 261-274

Reiter, L.; Kruithof, E.; Sordat, B. 1992: U pa u par expression and the invasive phenotype in vitro behavior of u pa transfected human colon carcinoma ht29 cells. Experientia 48(ABSTR): A93

Botto, H. 1991: U shape detubularized ileal bladder camey ii developing some technics to make it easier. Journal of Urology 145(4 Suppl): 203A

Botto, H.; Herve, J.M.; Barre, P.; Thebaut, Y.; Butreau, M.; Caney, M. 1992: U shaped detubularized ileal bladder camey ii results in 105 patients. Scandinavian Journal of Urology and Nephrology Suppl (142): 165

Filipowicz, W.; Kiss, T.; Marshallsay, C.; Waibel, F. 1990: U small nuclear rna genes u small nuclear rna and u small nuclear rnps of higher plants. Molecular Biology Reports 14(2-3): 125-130

Takeda, Y.; Wise, K.S.; Grady, G.; Wang, G.; Sharp, G.C.; Hardin, J.A. 1996: U snRNP-associated F78 particle is not recognized by IgM autoantibodies to B-1/B polypeptides which immunoprecipitate only U1 snRNP. Arthritis and Rheumatism 39(9 Suppl): S182

Kim, K.J.; Baik Han, E.J.; Chung, J.M. 1989: U turn afferent fibers in the rat ventral root. Society for Neuroscience Abstracts 15(1): 103

Wernicke Rolf, S.; Lippolt Hans, J. 1997: U+Th-He evidence of Jurassic continuous hydrothermal activity in the Schwarzwald basement, Germany. Chemical Geology 138(3-4): 273-285

Piercey, M.F.; Hoffmann, W.E.; Hyslop, D.K.; Camacho Ochoa, M.; Saleem, A.; Broderick, P.A. 1996: U-101387G, a selective antagonist of dopamine D-4 receptors, alters mesocorticolimbic dopamine release without altering nerve impulse rate. Society for Neuroscience Abstracts 22(1-3): 1772

Batts, D.H.; Borin, M.T.; Peel, B.G.; Hanover, C.K.; Brewer, J.E.; Francom, S.F.; Dietz, A.J. 1996: U-103017 Phase I, multiple-dose, safety, tolerance, and pharmacokinetics of the oral disodium salt in healthy volunteers. INFECTIOUS DISEASES SOCIETY OF AMERICA , NATIONAL INSTITUTES OF HEALTH , CENTERS FOR DISEASE CONTROL AND PREVENTION 3rd Conference on retroviruses and opportunistic infections : 81

Tayvek, J.A.; Lee, W.N.P.; Katz, J.A. 1995: U-13C-lactate infusion in humans to estimate Krebs cycle parameters. Journal of Investigative Medicine 43(Suppl 2): 402A

Thompson, A.C.; Shippenberg, T.S.; Justice, J.B. 1997: U-69593, A selective kappa-opioid receptor agonist, increases the rate of dopamine uptake in the N accumbens and striatum. Society for Neuroscience Abstracts 23(1-2): 693

Martin, K.J.; Mcconkey, C.; Jacobs, A.; Gonzalez, E.; Baldassare, J.J. 1993: U-73122 An inhibitor of phospholipase C, dissociates the effect of parathyroid hormone stimulated kinase-A and kinase-C activities in opossum kidney cells. Journal of the American Society of Nephrology 4(3): 724

Liu, P.; Vonderfect, S.L.; Fisher, M.A.; Mcguire, G.M.; Farhood, A.; Jaeschke, H. 1994: U-74006F protects against endotoxin shock and acute liver failure in rats. FASEB Journal 8(4-5): A125

Yue, G.; Sun, F.F.; Wong, P.Y.K. 1993: U-74006F, an antioxidant lazaroid, accelerates the healing of inflammatory bowel disease in rat. Gastroenterology 104(4 Suppl): A806

Qian, X.B.; Leblanc, M.H.; Patel, D.M.; Huang, M.; Smith, P.J.S.V.g And, E.E. 1996: U-74389G does not affect the severity of hypoxic ischemic brain injury in the piglet. Journal of Investigative Medicine 44(1): 75A

Sutton, R.L. 1994: U-74389G treatments after cortical contusion in the rat. Society for Neuroscience Abstracts 20(1-2): 192

Altavilla, D.; Squadrito, F.; Canale, P.; Ioculano, M.; Squadrito, G.; Campo, G.M.; Caputi, A.P. 1996: U-83836E, a new lazaroid, inhibits tumor necrosis factor-alpha and protects against endotoxin shock. Fundamental and Clinical Pharmacology 10(2): 161

Barbachyn, M.R.; Hutchinson, D.K.; Toops, D.S.; Reid, R.J.; Zurenko, G.E.; Yagi, B.H.; Schaadt, R.D.; Allison, J.W. 1993: U-87947E, a potent quinolone antibacterial agent incorporating a bicyclo pent-1-yl subunit. Bioorganic and Medicinal Chemistry Letters 3(4): 671-676

Toombs, C.F.; Shebuski, R.J. 1994: U-89232 , a novel antiischemic agent derived from cromakalim. Cardiovascular Drug Reviews 12(4): 303-316

Schreur, P.J.K.D.; Nichols, N.F.; Stone, M.P. 1992: U-91356A A novel dopamine agonist with potential antiparkinsonian activity. Society for Neuroscience Abstracts 18(1-2): 1081

Piercey, M.F.; Moon, M.W.; Hoffmann, W.E.; Walters, R.; Blanchette, P.; Bedard, P. 1992: U-91356a, a potent, effective, orally active D2 agonist potentially useful in treating Parkinsons disease. Society for Neuroscience Abstracts 18(1-2): 1081

Takashima, M.; Liou, S.Y.; Kunihara, M. 1994: U-92032, a T-type Ca channel blocker and antioxidant, inhibited glutamate release evoked by hypoxia. Japanese Journal of Pharmacology 64(Suppl 1): 207P

Schreur, P.J.K.D.; Stone, M.P.; Nichols, N.F.; Lin, C.H.; Haadsma Svensson, S.R. 1993: U-93385 An orally active anxiolytic with selective 5-HT-1A agonist activity. Society for Neuroscience Abstracts 19(1-3): 1867

Piercey, M.F.; Svensson, K.A.; Lin, C.H.; Haadsma Svensson, S.R.; Mccall, R.B.; Smith, M.W.; Broderick, P.A.; Carlsson, A. 1993: U-93385, a high intrinsic activity 5-HT1A agonist with good oral activity. Society for Neuroscience Abstracts 19(1-3): 1866

Dillon, G.H.; Im, H.; Hamilton, B.J.; Carter, D.B.; Gammill, R.B.; Im, W.B. 1993: U-93631 causes rapid decay of GABA-induced Cl current in recombinant rat GABA-A receptors. Society for Neuroscience Abstracts 19(1-3): 852

Mene, P.; Fais, S.; Cinotti, G.A.; Pugliese, F.; Thierauch, K.H. 1995: U-937 monocytes bind to and stimulate proliferation of cultured human mesangial cells Regulation by cytokines and vasoactive agents. Kidney International 47(2): 660

Cinotti, G.A.; Pugliese, F.; Mene, P. 1996: U-937 monocytes promote apoptosis of human mesangial cells Modulation by serum and thromboxane A-2. Journal of the American Society of Nephrology 7(9): 1694

Sethy, V.H.; Ellerbrock, B.R.; Wu, H. 1995: U-95666A A potential anti-Parkinson drug. Society for Neuroscience Abstracts 21(1-3): 1254

Schreur, P.J.K.D.; Nichols, N.F. 1995: U-95666A, a dopamine D2 agonist Behavioral studies in rats. Society for Neuroscience Abstracts 21(1-3): 853

Sethy, V.H.; Wu, H. 1996: U-95666E A potential neuroprotective drug. Society for Neuroscience Abstracts 22(1-3): 2133

Mcmichael, A.; Walker, E.L.; Piercey, M.F. 1997: U-99194A, a D-3 receptor antagonist, antagonizes increases in brain energy metabolism evoked by the psychotomimetic phencyclidine Implications for antipsychotic therapy. Society for Neuroscience Abstracts 23(1-2): 1930

Walker, E.L.; Smith, M.W.; Schreur, P.J.K.D.; Fitch, C.S.; Piercey, M.F. 1995: U-99194A, a D-3 receptor antagonist, selectively abolishes amphetamines non-striatal increases in brain energy metabolism Implications for antipsychotic therapy. Society for Neuroscience Abstracts 21(1-3): 857

Sambrook, J.F.; Madison, E.L.; Goldsmith, E.J.; Gething, M.H.; Gerard, R.D. 1998: U-PA mutants resistant to inhibition by their cognate inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1208(3): 2323

D.B.rt, A.C.W.; Quax, P.H.A.; Schalken, J.H.; Verheijen, J.H. 1994: U-PA production and u-PA mediated extracellular matrix degradation by rat prostate cancer cells in vitro correlates with metastatic behaviour in vivo. Fibrinolysis 8(Suppl 1): 57

McDonough, M.R.; McNicoll, V.J. 1997: U-Pb age constraints on the timing of deposition of the Waugh Lake and Burntwood Athabasca groups, southern Taltson magmatic zone, northeastern Alberta. Current Research - Geological Survey of Canada: 101-111

Lin Shoufa; Davis Donald, W.; Barr Sandra, M.; van Staal Cees, R.; Chen Yadong; Constantin Marc 2007: U-Pb geochronological constraints on the evolution of the Aspy Terrane, Cape Breton Island; implications for relationships between Aspy and Bras dOr Terranes and Ganderia in the Canadian Appalachians. American Journal of Science 307(2): 371-398

Poller Ulrike; Todt Wolfgang 2000: U-Pb single zircon data of granitoids from the High Tatra Mountains Slovakia; implications for the geodynamic evolution. Transactions of the Royal Society of Edinburgh: Earth Sciences 91, Parts 1-2: 235-243

Parent Martin; Machado Nuno; Zwanzig Herman, V. 1999: U-Pb system in monazite and chronology of deformation and metamorphism of the metasedimentary rocks of the Kisseynew Domain, Trans-Hudson Orogen Manitoba, Canada. Canadian Journal of Earth Sciences 36(11): 1843-1857

Almeida, A.; Leterrier, J.; Noronha, F.; Bertrand, J.M. 1998: U-Pb zircon and monazite geochronology of the Hercynian two-mica granite composite pluton of Cabeceiras de Basto northern Portugal. Comptes Rendus de l'Academie des Sciences, Serie II Sciences de la Terre et des Planetes

Esumi, H.; Tannenbaum, S.R. 1994: U.S.-Japan Cooperative Cancer Research Program: seminar on nitric oxide synthase and carcinogenesis. Cancer Research 54(1): 297-301

Yang Junlong; Yu Bisheng 1997: U-Th-Pb geochronology and lead isotope geochemistry of the Laerma carlin-type gold deposit in the western Qinling Mountains. Huanan Dizhi Yu Kuangchan = Geology and Mineral Resources of South China 1997(4(52)): 39-49

Min Kyoungwon; Reiners Peter, W.; Wolff John, A.; Mundil Roland; Winters, R.L.e 2006: U-Th/ He dating of volcanic phenocrysts with high U-Th inclusions, Jemez volcanic field, New Mexico. Chemical Geology 227(3-4): 223-235

Tagami Takahiro; Farley Kenneth, A.; Stockli Daniel, F. 2003: U-Th/ He geochronology of single zircon grains of known Tertiary eruption age. Earth and Planetary Science Letters 207(1-4): 57-67

Spikings, R.A.; Crowhurst, P.V. 2004: U-Th/ He thermochronometric constraints on the late Miocene-Pliocene tectonic development of the northern Cordillera Real and the Interandean Depression, Ecuador. Journal of South American Earth Sciences 17(4): 239-251

Herman Frederic; Braun Jean; Senden Tim, J.; Dunlap William, J. 2007: U-Th/ He thermochronometry; mapping 3D geometry using micro-X-ray tomography and solving the associated production-diffusion equation. Chemical Geology 242(1-2): 126-136

Reiners Peter, W.; Campbell, I.H.; Nicolescu, S.; Allen, C.M.; Hourigan, J.K.; Garver, J.I.; Mattinson, J.M.; Cowan, D.S. 2005: U-Th/ He-Pb double dating of detrital zircons. American Journal of Science 305(4): 259-311

Gautheron, C.E.; Tassan Got, L.; Farley, K.A. 2006: U-Th/ Ne chronometry. Earth and Planetary Science Letters 243(3-4): 520-535

Mitchell, J.J.; Vekemans, M.; Luscombe, S.; Hayden, M.; Weber, B.; Richter, A.; Sparkes, R.; Kojis, T.; Watters, G.; Der Kaloustian, V.M. 1994: U-type exchange in a paracentric inversion as a possible mechanism of origin of an inverted tandem duplication of chromosome 8. American Journal of Medical Genetics 49(4): 384-387

Lordereau Richard, I.; Georges, P.; Chaussain, J.L. 1993: U-hGH assay in Laron dwarfism. Pediatric Research 33(5 Suppl): S38

D.N.cola, L.; Georges, P.; Chaussain, J.L. 1998: U-hGH profile in normal subjects in growth retardation patients. Hormone Research (Basel) 50(Suppl 3): 137

Hadad, K.; Doulatdar, R. 2008: U-series concentration in surface and ground water resources of Ardabil province. Radiation Protection Dosimetry 130(3): 309-318

Burnett, W.C.; Glenn Craig, R.; Yeh, C.C.; Schultz, M.; Chanton, J.; Kashgarian, M. 2000: U-series, super 14 C, and stable isotope studies of Recent phosphatic protocrusts from the Peru margin. Special Publication - Society for Sedimentary Geology 66: 163-183

Kabakov, A.Y. 1995: U-shaped dependence of membrane potential on Na+-K+ pump activity. Biophysical Journal 68(2 Part 2): A231

Bae, O.-N.; Lim, K.-M.; Han, J.-Y.; Jung, B.-I.; Lee, J.-Y.; Noh, J.-Y.; Chung, S.-M.; Lee, M.-Y.; Lee, J.-Y.; Chung, J.-H. 2008: U-shaped dose response in vasomotor tone: a mixed result of heterogenic response of multiple cells to xenobiotics. Toxicological Sciences: An Official Journal of the Society of Toxicology 103(1): 181-190

Main, M.J.; Cannell, M.B. 1996: U-shaped inactivation curves recorded with Ba-2+ as the charge carrier through L-type calcium channels in isolated guinea-pig ventricular myocytes. Journal of Physiology (Cambridge) 497P: 127P-128P

Power, C.; Rodgers, B.; Hope, S. 1998: U-shaped relation for alcohol consumption and health in early adulthood and implications for mortality. Lancet 352(9131): 877

Bormann, J. 1992: U-tube drug application. Kettenmann, H, Grantyn, R Practical electrophysiological methods: A guide for in vitro studies in vertebrate neurobiology: 136-140

Hrasko, L. ubomir; Hatar Jozef; Huhma Hannu; Mantari Irmeli; Michalko Juraj; Vaasjoki Matti 1999: U/ Pb zircon dating of the Upper Cretaceous granite Rochovce type in the Western Carpathians. Krystalinikum 25: 163-171

Quinif, Y.; Bastin, B. 1994: U/Th dating and pollen analysis of a stalagmitic sequence of the isotopic stage 5. Comptes Rendus de l'Academie des Sciences Serie II Sciences de la Terre et des Planetes 318(2): 211-217

Vaux, P.; Waugh, R.; Brown, J.W.S. 1991: U1 and u2 small nuclear rnps in potato. Journal of Experimental Botany 42(238 Suppl): 36

L.X.; Rekosh, D.; Hammarskjold M L. 1990: U1 rna plays a role in the processing of rev dependent unspliced hiv1 env messenger rna. Journal of Cellular Biochemistry Suppl (14 Part D): 106

Rosbash, M.; Abovich, N.; Colot, H.V.; Goguel, V.; Liao, X. 1991: U1 small nuclear rnp and splice site choice in saccharomyces cerevisiae. Journal of Cellular Biochemistry Suppl (15 Part D): 46

Song, Y.; Zamrod, Z.; Stumph, W.E. 1993: U1 snRNA transcription is dependent upon the TATA-binding protein and two proximal motifs with a stringent spacing requirement. FASEB Journal 7(7): A1221

Morris, P.W.; Stetler, D.A. 1992: U1 snrna is required for rna polymerase i transcriptional activity. Biophysical Journal 61(2 Part 2): A73

Heinrichs, V.; Bach, M.; Luehrman, R. 1990: U1 specific protein c is required for efficient complex formation of u1 small nuclear rnp with a 5 splice site. Molecular Biology Reports 14(2-3): 165-166

Basu, M.K.; Makalowski, W.; Rogozin, I.B.; Koonin, E.V. 2008: U12 intron positions are more strongly conserved between animals and plants than U2 intron positions. Biology Direct 3: 19

Byers, D.M.; Carter, J.M.; Sparrow, S.M.; Cook, H.W.; Ridgway, N.D. 1997: U18666A inhibits regulation of intracellular cholesterol metabolism and neurotransmitter release in human neuroblastoma cells. FASEB Journal 11(9): A1097

Dugan, E.M.; Tunnessen, W.W.; Honig, P.J.; Watson, R.M. 1992: U1rnp neonatal lupus erythematosus a report of two cases with immunogenetic studies. Clinical Research 40(2): 271A

Pederson, T.; Kleinschmidt, A. 1990: U2 rna processing and small nuclear rnp assembly studied in vivo by rna transfection. Molecular Biology Reports 14(2-3): 179-`80

Temsamani, J.; Pederson, T. 1990: U2 small nuclear rnp associates with nuclear factors small nuclear after cytoplasmic assembly in a reaction requiring atp and the u2 small nuclear rnp specific a and b proteins. Journal of Cell Biology 111(5 Part 2): 246A

Organ, E.; Ruley, E.; Rubin, D.H. 1996: U3 gene-trap retrovirus selection of cellular mutants resistant to lytic reovirus infection. Journal of Investigative Medicine 44(3): 320A

Jacobson, M.R.; Pederson, T. 1996: U3 small nuclear RNA localizes in the nucleolus via a cap-dependent mechanism. Molecular Biology of the Cell 7(Suppl ): 106A

Glibetic, M.; Larson, D.E.; Sienna, N.; Sells, B.H. 1990: U3 small nuclear rna expression is repressed during a down shift in ribosomal rna synthesis. Journal of Cell Biology 111(5 Part 2): 247A

Withrington P.G.; Antunes E.; Grassi Kassisse D.M.; De Nucci G. 1992: U46619 a stable thromboxane mimetic can constrict the canine splenic arterial vasculature without significant effect on capsular smooth muscle. British Journal of Pharmacology 105(Proceedings Suppl APRIL): 306P

Perez Vizcaino, F.; Villamor, E.; Del Pozo, F.F.; Fernandez, C.; Tamargo, J. 1997: U46619 and endothelin-1 inhibit the relaxant responses via cGMP pathway in piglet pulmonary arteries. British Journal of Pharmacology 120(Proceedings Suppl ): 149P

Maisonneuve, I.M.; Glick, S.D. 1994: U50,488, A Kappa agonist, attenuates cocaine-induced increases in extracellular dopamine in nucleus accumbens. Society for Neuroscience Abstracts 20(1-2): 1634

Hubbell, C.L.; Barringer, T.M.; Gonzales, P.M.; Moran, C.M.; Reid, L.D. 1996: U50,488, a kappa opioid agonist, and cocaines reward-relevant effects. Society for Neuroscience Abstracts 22(1-3): 703

Carden, S.E.; Bortot, A.T.; Hofer, M.A. 1992: U50488 and pentylenetetrazole, but not naltrexone, elicit ultrasonic vocalizations from rat pups in the homecage. Society for Neuroscience Abstracts 18(1-2): 659

Widmayer, M.A.; Browning, J.L.; Baskin, D.S. 1992: U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia. Society for Neuroscience Abstracts 18(1-2): 1255

Patterson, A.B.; Holtzman, S.G. 1996: U69,593, a K-opioid receptor agonist, potentiates the antinociceptive effects of cocaine in the hot-plate assay. Society for Neuroscience Abstracts 22(1-3): 1684

Gray, A.M.; Mcginty, J.F. 1997: U69,593, a kappa opioid receptor agonist, decreases amphetamine-evoked extracellular dopamine levels in the nucleus accumbens of conscious rats. Society for Neuroscience Abstracts 23(1-2): 2145

Grierson, J.P.; Meldolesi, J. 1993: U73122, a phospholipase C inhibitor, alters Ca-2+ homeostasis in PC12 and fibroblast cells. Society for Neuroscience Abstracts 19(1-3): 751

Kong, Y.; Ye, J.; Lesnefsky, E.J.; Horwitz, L.D. 1993: U74006F prevents myocardial lipid preoxidation and reduces ventricular dysfunction due to iron-catalyzed oxygen free radical reactions. FASEB Journal 7(3-4): A102

Bergeron, Y.; Morin, N.J.; Cantin, M.F.; Bergeron, M.G. 1993: U74389F, a new 21-aminosteroid, as antioxidant therapy in a rat model of endotoxemic shock. Clinical and Investigative Medicine 16(4 Suppl): B79

Duguay, P.; Chen, H.F.; Daloze, P.; Senechal, J.; Dumont, L. 1995: U74389G, A 21-aminosteroid inhibitor of lipid peroxidation, affords significant cardioprotection following prolonged hypothermic storage and transplantation of rat hearts. FASEB Journal 9(4): A894

Hays, A.M.; Lantz, R.C.; Vermuelen, M.; Chen, G.; Witten, M.L. 1993: U75412E pretreatment before acute smoke exposure causes a large increase in lung prostacyclin concentrations. FASEB Journal 7(3-4): A507

Figueroa, J.T.; Liebler, D.C.; Hays, A.M.; Lantz, R.C.; Vermuelen, M.; Chen, G.; Witten, M.L. 1993: U75412E pretreatment before acute smoke exposure increases BAL vitamin E levels. FASEB Journal 7(3-4): A408

Gaetani, P.; Marzatico, F.; Cafe, C.; Messina, A.L.; Rodriguez, Y.Baena, R. 1993: U78517F treatment after experimental SAH Effects on lipid peroxidative patterns in synaptosomal cortical preparations. Canadian Journal of Neurological Sciences 20(Suppl 1): S29

Peculis, B.A. 1995: U8 and U14 snoRNAS are essential for pre-rRNA processing in vertebrates. Molecular Biology of the Cell 6(Suppl ): 195A

Nolfo, R.; Rankin, J.A. 1989: U937 and thp 1 cells do not release ltb4 ltc4 or ltd4 in response to a 23187. American Review of Respiratory Disease 139(4 Part 2): A93

Mitchell, F.M.; Milligan, G. 1991: U937 cell differentiation: G protein alterations and interaction with the chemotactic peptide receptor. Biochemical Society Transactions 19(2): 98s

Li, Y.; Aarons, R.; Hilliard, L.; Howard, T. 1996: U937 cell motility is modulated by level of leufactin The actin binding protein overexpressed in NAD 47/89, a defect of human neutrophil motility. Blood 88(10 Suppl 1 Part 1-2): 155A

Koehler, L.; Nettelnbrecker, E.; Holtmann, H.; Zeidler, H. 1993: U937 cells as a model for infection of monocytic cells with Chlamydia trachomatis. Immunobiology 189(1-2): 179

Stoolman, L.M.; Abassi, O.; Craig, R. 1994: U937 cells use both E-selectin and alpha-4-containing integrins to initiate contact with cytokine-treated endothelium under shear-stress. FASEB Journal 8(4-5): A894

Jobe, C.D.; Parmely, M.J. 1992: U937 promonocytic cells inactivate the bioactivity of interferon gamma by direct plasmin proteolysis. FASEB Journal 6(4): A1329

Lajiness, M.E.; Chio, C.L.; Schreur, P.J.K.D.; Huff, R.M. 1996: U95666A is a high intrinsic activity agonist with selectivity for the D2 dopamine receptor. Society for Neuroscience Abstracts 22(1-3): 217

Muccio, D.D.; Brouillette, W.J. 1998: UAB retinoids in chemoprevention and leukemia therapy. Abstracts of Papers American Chemical Society 216(1-3): MEDI 376

Worgul, B.V.; Likhtaryov, I.; Kundiev, Y.; Medvedovsky, C.; Sergienko, N.; Wu, B.; Parkhomenko, G.; Chumak, B.; Ruban, A. 1994: UACOS A Ukrainian American Chernobyl Ocular Study. IOVS Investigative Ophthalmology and Visual Science: 35(4)

Nass, A.; Schuell, C.; Grimm, M.; Beier, H. 1994: UAG readthrough during translation of carnation mottle virus RNA. Biological Chemistry Hoppe-Seyler 375(SPEC Suppl 1): S76

Sharples, C.G.; Kaiser, S.A.; Mogg, A.J.; Wright, E.; Gallagher, T.; Wonnacott, S. 1998: UB-165 A novel epibatidine-anatoix-a hybrid that is a nicotinic agonist with subtype selectivity. Society for Neuroscience Abstracts 24(1-2): 86

Sanchez Carbayo, M.; Megias, J.; Molina, R.; Mira, A.; Filella, X.; Ballesta, A.; Soria, F. 1998: UBC rapid test as a new tumor marker in the diagnosis of bladder cancer. Tumor Biology 19(Suppl 2): 72

Robinson, M. 1996: UBC researcher's back-pain studies focus on space travel. Cmaj: Canadian Medical Association Journal 154(1): 94-95

Sanchez Carbayo, M.; Megias, J.; Molina, R.; Mira, A.; Filella, X.; Ballesta, A.; Soria, F. 1998: UBC, a new tumor marker in the diagnosis of bladder cancer. Tumor Biology 19(Suppl 2): 72

Bandman, O.; Goli, S.K. 1998: UBCH7-like ubiquitin-conjugating enzyme. Official Gazette of the United States Patent and Trademark Office Patents 1217(2): 1650

Buerger, J.; Hennies, H.C.; Sperling, K.; Reis, A. 1998: UBE3A gene expression in Angelman syndrome patients with imprinting defects. European Journal of Human Genetics 6(Suppl 1): 140

Kishino, T.; Lalande, M.; Wagstaff, J. 1997: UBE3A/E6-AP mutations in Angelman syndrome indicate a role for the ubiquitin pathway in brain development. American Journal of Human Genetics 61(4 Suppl): A39

Pikaard, C.S.; Copenhaver, G.P.; Putnam, C.D.; Denton, M.L. 1994: UBF-nucleic acid interactions and the molecular evolution of ribosomal gene enhancers. Journal of Cellular Biochemistry Suppl 1994(18C): 69

Luo, M.; Luo, M.-Z.; Buzas, D.; Finnegan, J.; Helliwell, C.; Dennis, E.S.; Peacock, W.J.; Chaudhury, A. 2008: UBIQUITIN-SPECIFIC PROTEASE 26 is required for seed development and the repression of PHERES1 in Arabidopsis. Genetics 180(1): 229-236

Lung, E.; Schilling, M.; Steuhl, K.P.; Wessing, A. 1997: UBM in comparison with standardized A-scan/B-scan echography in melanomas of the peripheral UVEA and ciliary body A pilot study. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S1070

Kuhn Emil 1946: UBeta er Acrodus-Funde aus dem Grenzbitumenhorizont der anisischen Stufe der Trias des Monte San Giorgio Kt Tessin. Eclogae Geologicae Helvetiae 38(2): 662-673

Wang, F.; Li, X.; Xie, X.; Zhao, L.; Chen, W. 2008: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. Febs Letters 582(13): 1919-1927

Takahashi, I.; Maruta, R.; Ando, K.; Yoshida, M.; Iwasaki, T.; Kanazawa, J.; Okabe, M.; Tamaoki, T. 1993: UCA1064-B, a new antitumor antibiotic isolated from Wallemia sebi: production, isolation and structural determination. Journal of Antibiotics 46(8): 1312-1314

Fujii, N.; Yamashita, Y.; Ando, K.; Agatsuma, T.; Saitoh, Y.; Gomi, K.; Nishiie, Y.; Nakano, H. 1994: UCE1022, a new antitumor antibiotic with topoisomerase i mediated DNA cleavage activity, from Paecilomyces. Journal of Antibiotics 47(8): 949-951

Fujii, N.; Yamashita, Y.; Chiba, S.; Uosaki, Y.; Saitoh, Y.; Tuji, Y.; Nakano, H. 1993: UCE6, a new antitumor antibiotic with topoisomerase i mediated DNA cleavage activity, from actinomycetes. Journal of Antibiotics 46(7): 1173-1174

Nakano, H.; Hara, M.; Akasaka, K.; Akinaga, S.; Okabe, M.; Gomez, R.; Wood, D.; Uh, M.; Tamanoi, F. 1993: UCF1, protein farnesyltransferase inhibitors from Streptomyces Antitumor activity in murine tumors models with activated ras. Proceedings of the American Association for Cancer Research Annual Meeting 34: 386

Nagase, T.; Kawata, S.; Yamazaki, E.; Ishiguro, H.; Matuzawa, Y. 1993: UCF1-C potently inhibits growth of Hep G2 cells by suppressing protein farnesyltransferase activity. Hepatology 18(4 Part 2): 190A

Carpenter, P.M.; Gamboa-Vujicic, G.; Mascarello, J.T.; Wilczynski, S.; Bhaumik, M.; Dorion, G.; Manetta, A. 1995: UCI-VULV-1, a vulvar squamous carcinoma cell line. Gynecologic Oncology 57(2): 191-198

Mizukami, T.; Asai, A.; Yamashita, Y.; Katahira, R.; Hasegawa, A.; Ochiai, K.; Akinaga, S. 1997: UCK14 compounds. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 478

D.L.Colbern, Et@al 1995: UCLA Kids Judge Neuroscience Fair. Society for Neuroscience Abstracts 21(1-3): 250

Light, R.; Asarnow, R.F.; Satz, P.; Zaucha, K.; Lewis, R. 1993: UCLA studies of mild closed-head injury III Behavioral and academic outcomes. Journal of Clinical and Experimental Neuropsychology 15(1): 20-21

Grever, M.R.; Shinn, C.; Levy, J. 1995: UCN-01 A new potential therapeutic agent for chronic lymphocytic leukemia. Blood 86(10 Suppl 1): 349A

Byrd, J.C.; Shinn, C.A.; Bedi, A.; Waselenko, J.K.; Flinn, I.W.; Diehl, L.F.; Sausville, E.; Grever, M.R. 1997: UCN-01 A promising new agent for B-cell chronic lymphocytic leukemia that induces apoptosis independent of p53 status. Blood 90(10 Suppl 1 Pt 2): 306B

Husain, A.; Rosales, N.; Schwartz, G.K.; Spriggs, D.R. 1997: UCN-01 enhances CDDP cytotoxicity in ovarian cancer cells independent of p53 gene status and abrogation of G2 block. Proceedings of the American Association for Cancer Research Annual Meeting 38: 321

Shinn, C.A.; Byrd, J.C.; Waselenko, J.K.; Sausville, E.; Miller, C.; Gore, S.; Grever, M.R. 1997: UCN-01 has significant in vitro activity in both the resistant K562 cell line and human acute leukemia cells. Blood 90(10 Suppl 1 Pt 2): 246B

Mack, P.C.; Edelman, M.J.; Gandara, D.R.; Gumerlock, P.H. 1998: UCN-01 synergizes with cisplatin in non-small cell lung carcinoma cell lines with wild-type and mutant RB and p53. Journal of Investigative Medicine 46(1): 126A

Kruger, E.A.; Blagosklonny, M.V.; Dixon, S.C.; Figg, W.D. 2000: UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response. Invasion and Metastasis 18(4): 209-218

Pollack, I.F.; Kawecki, S.; Rusnak, J.M.; Lazo, J.S. 1996: UCN-01, a selective protein kinase C inhibitor, blocks glioma proliferation and induces apoptosis in vitro and inhibits glioma growth in vivo. Proceedings of the American Association for Cancer Research Annual Meeting 37: 424

Yu, L.; Orlandi, L.; Wang, P.; Krawchuk, D.; Rucker, K.; O'connor, P.M. 1998: UCN-01-induced G2 checkpoint abrogation requires a functional Cdc2 kinase and is associated with inactivation of the Wee1 kinase. Proceedings of the American Association for Cancer Research Annual Meeting 39: 178

Saito, M.; Irie, Y.; Asano, A.; Nikami, H.; Kimura, K. 1998: UCP expression in immortal brown adipocytes isolated from p53-deficient mice. International Journal of Obesity 22(Suppl 3): S14

Davis, L.M.; Rho, J.M.; Sullivan, P.G. 2008: UCP-mediated free fatty acid uncoupling of isolated cortical mitochondria from fasted animals: correlations to dietary modulations. Epilepsia 49(Suppl 8): 117-119

Boss, O.; Bobbioni Harsch, E.; Assimacopoulos Jeannet, F.; Muzzin, P.; Muenger, R.; Giacobino, J.P.; Golay, A. 1998: UCP3 expression in skeletal muscle and free fatty acids in obese humans. International Journal of Obesity 22(Suppl 3): S60

D.J.ng, P.J.; Merckelbach, H.; Koertshuis, G.; Muris, P. 1994: UCS-inflation and acquired fear responses in human conditioning. Advances in Behaviour Research and Therapy 16(3): 131-165

Mizukami, T.; Ogawa, H.; Nakai, R.; Asai, A.; Yamashita, Y.; Ando, K.; Agatsuma, T.; Akinaga, S.; Ouchi, K.; Kawasaki, H. 1998: UCS1025 compounds. Official Gazette of the United States Patent and Trademark Office Patents 1213(4): 3740-3741

Kneller, D.G.; Kuntz, I.D. 1993: UCSF Sparky An NMR display, annotation and assignment tool. Journal of Cellular Biochemistry Suppl 1993(17 Part C): 254

Day, M.R.; Kuntz, I.D. 1993: UCSF Striker An interactive processing tool for multi-dimensional NMR data. Journal of Cellular Biochemistry Suppl 1993(17 Part C): 251

Kanatakis, S.; Koutsis, D.; Aggelou, A.; Moussionis, A.; Dritsas, S. 1998: UDCA Alternative treatment in distinct categories of patients with chronic hepatitis C. Journal of Hepatology 28(Suppl 1): 208

Mazzella, G.; Salzetta, A.; Morelli, M.C.; Novelli, V.; Festi, D.; Polifemo, A.M.; Cipolla, A.; Roda, E. 1993: UDCA as adjuvant therapy in patients not responding to interferon treatment. Journal of Hepatology 18(Suppl 1): S52

Yan, C.C.; Bellentani, S.; Tiribelli, C.; Manenti, F. 1993: UDCA, TUDCA and taurine chronic oral administration changes total lipids content and fatty acids composition of hepatic microsomes in the rat. Journal of Hepatology 18(Suppl 1): S188

Zeniya, M.; Watanabe, F.; Urano, Y.; Kato, A.; Toda, G. 1996: UDCA-Equivalent increase in bilirubin secretion by folinic acid on cholestasis. Hepatology 24(4 Part 2): 216A

Oyaizu, M.; Sato, R.; Kasugai, H.; Saito, M.; Narahashi, T. 1997: UDCG-212, a new positive inotropic agent, blocks inwardly rectifying K+ channel in human ventricular myocytes. Biophysical Journal 72(2 Part 2): A253

Schulze Lohoff, E.; Hugo, C.; Rost, S.; Chang, K.; Takuwa, Y.; Ogilvie, A.; Sterzel, R.B. 1997: UDP increases intracellular calcium, c-fos expression and DNA synthesis in mesangial cells via specific UDP receptors. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 407A

Fricks, I.P.; Maddileti, S.; Carter, R.L.; Lazarowski, E.R.; Nicholas, R.A.; Jacobson, K.A.; Harden, T.K. 2008: UDP is a competitive antagonist at the human P2Y14 receptor. Journal of Pharmacology and Experimental Therapeutics 325(2): 588-594

Chapeau, M.C.; Frey, P.A. 1994: UDP-4-deoxy-fluoro glycosides Synthesis and study with UDP-galactose-4-epimerase. Abstracts of Papers American Chemical Society 208(1-2): CARB 21

Kariya, M.; Namiki, H. 1995: UDP-4ketoglucosamine as a reducing factor. Zoological Science 12(Suppl ): 48

Trombetta, S.; Sousa, M.; Parodi, A.J. 1993: UDP-GLC Glycoprotein glucosyltransferase, its possible involvement in glycoprotein folding. Molecular Biology of the Cell 4(Suppl ): 229A

Roth, J. 1997: UDP-GlcGlycoprotein glucosyltransferase is present in the ER and the intermediate compartment. Glycoconjugate Journal 14(6): 756

D.S.aso, S.; Visconti, U.; Balestrazzi, E. 1995: UDP-Glucose dehydrogenase activity and lactate production in normal and glaucomatous human trabecular meshwork cells. IOVS Investigative Ophthalmology and Visual Science 36(4): S728

Banhegyi, G.; Braun, L.; Marcolongo, P.; Fulceri, R.; Csala, M.; Mandl, J.; Benedetti, A. 1995: UDP-Glucuronic Acid-phenol glucuronide antiport in rat liver microsomal vesicles. Journal of Hepatology 23(Suppl 1): 163

Majumdar, S.; Bhattacharjee, H.; Bhattacharyya, D.; Bhaduri, A. 1998: UDP-galactose 4-epimerase from Kluyveromyces fragilis: reconstitution of holoenzyme structure after dissociation with parachloromercuribenzoate. European Journal of Biochemistry 257(2): 427-433

Ohta, H.; Shimojima, M.; Arai, T.; Masuda, T.; Shioi, Y.; Takamiya, K.I.hiro 1995: UDP-galactose Diacylglycerol galactosyltransferase in cucumber seedlings Purification of the enzyme and the activation by phosphatidic acid. Kader, J -C , Mazliak, P Plant lipid metabolism 152-155

Alano, A.; Almashanu, S.; Maceratesi, P.; Reichardt, J.; Panny, S.; Cowan, T.M. 1997: UDP-galactose-4-epimerase deficiency among African Americans Evidence for multiple alleles. Journal of Investigative Medicine 45(1): 191A

Popko, B.; Coetzee, T.; Dupree, J.; Fujita, N.; Suzuki, K.; Suzuki, K. 1997: UDP-galactoseceramide galactosyltransferase Molecular and functional analysis. Journal of Neurochemistry 69(Suppl ): S95

Barreiro, R.; Cheeseman, J. 1995: UDP-glucose dehydrogenase and the mechanism of carbon partitioning during cell growth. Plant Physiology (Rockville) 108(2 Suppl): 55

Zimmermann, A.; Blaszkewicz, M.; Roth, G.; Seidel, T.; Dietrich, H.; Schutschkow, O.; Bolt, H.M.; Golka, K. 2008: UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases. Journal of Toxicology and Environmental Health. Part A 71(13-14): 911-914

Prentice, D.A.; Mashford, M.L.; Desmond, P.V. 1997: UDP-glucuronosyltransferase isoform messenger RNA levels in bild duct ligated rats. Gastroenterology 112(4 Suppl): A1362

Nishiyama, T.; Ohnuma, T.; Inoue, Y.; Kishi, T.; Ogura, K.; Hiratsuka, A. 2008: UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation. Biochemical and Biophysical Research Communications 371(2): 247-250

Bock, K.W. 1994: UDP-glucuronosyltransferases and their role in metabolism and disposition of carcinogens. Advances in Pharmacology 27: 367-383

Tukey, R.H.; Nguyen, N.; Straub, P.; Lamb, G.; Durazzo, M.; Philipp, T.; Manns, M. 1994: UDP-glucuronosyltransferases are epitopes for LKM-3 autoantibodies in chronic hepatitis D. FASEB Journal 8(7): A1468

Conner, C.E.; Burchell, B.; Hume, R. 1997: UDP-glucuronyl transferase enzyme family in both human and Balb/c mouse lung. Biochemical Society Transactions 25(2): 181s

Conner, C.E.; Burchell, B.; Hume, R. 1996: UDP-glucuronyl transferase enzyme system in both human and BALB/c mouse lung. Immunology 89(Suppl 1): 36

Kane, A.S.; Kahng, M.W.; Reimschuessel, R.; Nhamburo, P.T.; Lipsky, M.M. 1994: UDP-glucuronyltransferase kinetics for 3-trifluoromethyl-4-nitrophenol in fish. Transactions of the American Fisheries Society 123(2): 217-222

Zeng,W.; Chatterjee,M.; Faik,A. 2008: UDP-xylose-stimulated glucuronyltransferase activity in wheat microsomal membranes characterization and role in glucurono xylan biosynthesis. Plant Physiology 7(1): 78-91

Stolfi, R.L. 1996: UDPG as a recue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without BAU. Official Gazette of the United States Patent and Trademark Office Patents 1183(4): 2222

Stolfi, R.L. 1996: UDPG as a rescue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without bau. Official Gazette of the United States Patent and Trademark Office Patents 1189(1): 425

Sheen, Y.Y.; Owens, I.S.; Kim, S.S.; Kim, J.E. 1998: UDPGT cDNA expression and UDPGT1 in human liver. Journal of Toxicological Sciences 23(Suppl 2): 136-139

Berthelsen, J.; Consalez, G.G.; Viggiano, L.; Rocchi, M.; Blasi, F. 1997: UEF3-p64 gene, encoding a new homeo-protein binding PBX1, maps in the distal region of 21q. Cytogenetics and Cell Genetics 79(1-2): 41

Li, Q.; Castell, J.A.; Castell, D.O. 1993: UES relaxation and prepharyngeal pressure in response to the change of bolus size and consistency. Gastroenterology 104(4 Suppl): A542

Jacangelo, J.G.; Laine, J.M.; Cummings, E.W.; Adham, S.S. 1995: UF with pretreatment for removing DBP precursors. Journal - American Water Works Association 87(3): 100-112

Kizaki, M.; Takayama, N.; Matsushita, H.; Ikeda, Y. 1996: UF-1, a novel retinoic acid-resistant cell line established from a patient with acute promyelocytic leukemia. Proceedings of the American Association for Cancer Research Annual Meeting 37: 501

Deng,Z.N.; Harbaugh,B.K.; Peres,N.A. 2008: UF-331 and UF-340 new dwarf caladium cultivars for landscape and pot plants. HortScience 7: 2231-2235

Deng,Z.N.; Harbaugh,B.K.; Peres,N.A. 2008: UF-404 - dwarf, red caladium for container-forcing and sunny landscapes. HortScience 43(6)

Samach, A.; Kohalmi, S.; Haughn, G.; Crosby, W. 1997: UFO encounters of a floral kind. Plant Physiology (Rockville) 114(3 Suppl): 60

Kim, H.H.; Tam, J.W.; Chan, K.L. 1995: UFO in atria and pulmonary veins Is it a real phenomenon?. Circulation 92(8): I538

Coleman, T.J.; Schlotter, W.K.I.; Coleman, P.A.; Schlotter, A.M. 1997: UFO pop. Official Gazette of the United States Patent and Trademark Office Patents 1203(2): 1263

González Barón, M.; Feliu, J.; Garcia Girón, C.; Espinosa, J.; Martinez, B.; Blanco, E.; Crespo, M.C.; Ordóñez, A.; Espinosa, E.; de Castro, J.; Juárez, F.; Colmenarejo, A. 1997: UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience. Oncology 54(Suppl): 24-29

Hatfield, D.; Diamond, A. 1993: UGA: a split personality in the universal genetic code. Trends in Genetics: Tig 9(3): 69-70

Hu, P.Y.; Ernst, A.R.; Sly, W.S. 1992: UGA suppression of Hispanic Mutation for CA II deficiency syndrome suggests novel mechanism for genetic heterogeneity. American Journal of Human Genetics 51(4 Suppl): A29

A.A.si, M.T.; Genta, R.M.; Karttunen, T.J.; Graham, D.Y. 1995: UGI bleeding and gastric ulcer location are independent clues to NSAID use in patients with peptic ulcer regardless of H pylori status. Gut 37(Suppl 1): A89

Walker, R.; Cornelissen, G.; Haus, E.; Zaslavskaya, R.M.; Halberg, E.; Halberg, F. 1994: UGP for diagnosis of ovarian cancer and chronobiology. Proceedings of the American Association for Cancer Research Annual Meeting 35: 204

Monaghan, G.; Foster, B.; Jurima-Romet, M.; Hume, R.; Burchell, B. 1997: UGT1*1 genotyping in a Canadian Inuit population. Pharmacogenetics 7(2): 153-156

Iolascon, A.; Faienza, M.F.; Giordani, L.; Perrotta, S.; Meloni, M.F.; Guggiu, G.; Miraglia Del Giudice, E. 1998: UGT1A promoter polymorphism differently contributes to jaundice in inherited hemolytic anemias of newborn. European Journal of Human Genetics 6(Suppl 1): 130-131

Limenta, L.M.G.; Jirasomprasert, T.; Tankanitlert, J.; Svasti, S.; Wilairat, P.; Chantharaksri, U.; Fucharoen, S.; Morales, N.P. 2008: UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers. British Journal of Clinical Pharmacology 65(6): 908-916

Franklin, M.R.; Nguyen, N.T.; Tukey, R.H. 1993: UGT2C1 The first of a new subfamily of UDP-glucuronosyltransferases identified from a rabbit liver cDNA library. FASEB Journal 7(7): A1202

Orel, V.E.; Danko, M.I.; Dzyatkovskaya, N.M. 1997: UHF inductive hyperthermia of mechanochemically activated sodium chloride. Dopovidi Natsional'noyi Akademiyi Nauk Ukrayiny 1997(7): 185-187

Clay, T.M.; Culpan, D.; Howell, W.M.; Sage, D.A.; Bidwell, J.L.; Bradley, B.A. 1994: UHG crossmatching A novel approach to selecting HLA-DPB1 compatible donors for BMT. Bone Marrow Transplantation 1994(PROGRAM ABSTR ): 158

Clay, T.; Culpan, D.; Howell, W.M.; Sage, D.; Bidwell, J.; Bradley, B.A. 1994: UHG crossmatching for the selection of HLA-DPB1 compatible bone marrow donors. Human Immunology 39(2): 150

Neaves, P. 1995: UHT plant cleaning Problems and solutions. International Biodeterioration and Biodegradation 36(3-4): 461-462

Burger, M.M.; Moses, H.L. 1997: UICC Study Group on Basic and Clinical Cancer Research: mechanisms of growth factor and hormone insensitivity. International Journal of Cancer 73(4): 461-463

Burger, M.M.; Harlow, E. 1995: UICC Study group on basic and clinical cancer research Cell-cycle control A target for therapy?. International Journal of Cancer 63(3): 321-323

Oommen, P.T.; Romahn, A.; Linden, T.; Frühwald, M.C.; Bucsky, P. 2008: UICC-2002 TNM classification is not suitable for differentiated thyroid cancer in children and adolescents. Pediatric Blood and Cancer 50(6): 1159-1162

Jackson, C.; Best, N.; Elliott, P. 2008: UK Biobank Pilot Study: stability of haematological and clinical chemistry analytes. International Journal of Epidemiology 37(Suppl 1): I16-I22

Phillips, C.P.; Court, D.S.; Tamaki, N. 1998: UK Caucasian databases for the short tandem repeat loci D21S11, HUMFIBRA and D8S1179. Olaisen, B, Brinkmann, B, Lincoln, P J International Congress Series; Progress in Forensic Genetics, 7 398-400

Arlett, P.R.; Lee, E.H.; Cave, A.C.; Hooker, M.; Darbyshire, J.H.; Breckenridge, A.M.; Rawlins, M. 1998: UK HIV adverse drug reactions reporting scheme. AIDS 12(Suppl 4): S55

Allan, N.; Richards, S.; Shepherd, P. 1994: UK MRC randomised trial of interferon-alpha in chronic phase chronic myeloid leukaemia. British Journal of Haematology 87(Suppl 1): 164

Mccoll, K.E.L.; Murray, L.S.; El Omar, E.; Kelman, A.W.; Dickson, A.; El Nujumi, A.; Wirz, A.; Knill Jones, R.; Penney, C.; Cochrane, K.; Danesh, B.; Gaw, N.; Wilson, F. 1998: UK MRC trial of H pylori eradication therapy for non-ulcer dyspepsia. Gastroenterology 114(4 Part 2): A222

Anonymous 1982: UK Minerals in 81. Industrial Minerals (London) 179): 17

Jennings, I.; Woods, T.A.L.; Kitchen, S.; Preston, F.E. 1996: UK NEQAS for blood coagulation Detection of the lupus anticoagulant. British Journal of Haematology 93(Suppl 2): 316-317

Miller, K.; Rhodes, A.; Mepham, B.; Warford, A.; Kirkham, N. 1993: UK NEQAS for immunocytochemistry A review of recent results. Journal of Pathology 169(Suppl): 126A

Mckee, G.; Robinson, I. 1994: UK National Breast Screening Programme The cytopathologists role. Acta Cytologica 38(5): 865

Campbell, I.; Seal, D.V.; Hay, J.; Mcluckie, J.; Patterson, W. 1994: UK National Study of Legionella contamination of hospital transplant units Relevance of free-living amoebae. Journal of Medical Microbiology 41(Suppl 1): ABSTRACT 288

Cornish, J. 1994: UK Paediatric Bone Marrow Transplant Group National Registry. Bone Marrow Transplantation 1994(PROGRAM ABSTR ): 112

Hann, C.M. 1994: UK Poultry Research Liaison Group. British Poultry Science 35(5): 818-819

U.K.Prospective Diabetes Study Group 1993: UK Prospective Diabetes Study X Urinary albumin excretion over 3 years in diet-treated type 2, diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 36(10): 1021-1029

Hamilton, S.L.; Clemes, S.A.; Griffiths, P.L. 2008: UK adults exhibit higher step counts in summer compared to winter months. Annals of Human Biology 35(2): 154-169

Carruthers, D.J.; Mchugh, C.A.; Robins, A.G.; Thomson, D.J.; Davies, B.; Montgomery, M. 1994: UK atmospheric dispersion modelling system Validation studies. Gryning, S -E , Millan, M M NATO Challenges of Modern Society; Air pollution modeling and its application X 491-501

Rahman, S.; Emery, A.; Poulton, J. 1998: UK centres are not following the Royal College of Pathologists' recommendations for storage of Guthrie cards: a national policy is needed. Journal of Medical Genetics 35(3): 263

O'Brien,G. 2008: UK emergency preparedness a holistic response?. Disaster Prevention and Management: 2, 232-243

Wilson, P.; Cutler, R.R.; Clarke, F.V. 1996: UK evaluation of the BBL mycobacterial growth indicator tube for the detection of mycobacteria in clinical specimens. Abstracts of the General Meeting of the American Society for Microbiology 96: 3

Rickard,S.; Roberts,D.L. 2008: UK farming post reform the key marketing challenges. Journal Of International Food and Agribusiness: 1, 5-27

Williamson, L.M. 1995: U.K. guidelines for the irradiation of blood components. Transfusion Science 16(2): 135-137

Milburn,R.; Hall,L. 2008: UK hotels early check-out for good times. Hospitality Directions: , 1-6

Leeuwen,S.van 2008: UK hotels forecast the bigger the boom, the bigger the bust. Hospitality Directions: , 1-23

Cookson, B.D.; Valtz, N.; Marples, R. 1998: UK infection control team methicillin-resistant Staphylococcus aureus questionnaire Control information. Journal of Hospital Infection 40(Suppl A): P3168

Cookson, B.D.; Marples, R. 1998: UK infection control team methicillin-resistant Staphylococcus aureus questionnaire Descriptive data. Journal of Hospital Infection 40(Suppl A): P3169

Wardrope, J. 1992: UK major trauma outcome study. Bmj 305(6860): 1016

McClean,H.; Carne,C.; Bunting,P.; Bhaduri,S.; Fernandes,A.; Dhar,J.; Estreich,S.; Daniels,D. 2008: UK national audit of chlamydial infection management in sexual health clinics Case notes audit demography, diagnosis and treatment. International Journal Of Std and Aids: 7, 469-472

McClean,H.; Carne,C.; Bunting,P.; Bhaduri,S.; Fernandes,A.; Dhar,J.; Estreich,S.; Daniels,D. 2008: UK national audit of chlamydial infection management in sexual health clinics Case notes audit information-giving, partner notification and follow-up. International Journal Of Std and Aids: 7, 473-476

Carne, C.; McClean, H.; Bhaduri, S.; Bunting, P.; Fernandes, A.; Dhar, J.; Estreich, S.; Daniels, D. 2008: UK National Audit of chlamydial infection management in sexual health clinics. clinic policies audit. International Journal of Std and Aids 19(7): 477-479

Wilkinson, I.M.S. 1992: UK national audit of the care of common neurological disorders. Journal of Neurology Neurosurgery and Psychiatry 55(12): 1215

Miller, K.; Rhodes, A. 1995: UK national external quality assessment scheme for immunocytochemistry An overview. Pathology Research and Practice 191(7-8): 730

Barlow, D.H. 1995: UK prevalence study of urogenital ageing. Barlow, D H Royal Society of Medicine Services Round Table Series; Towards better recognition of urogenital ageing 5-6

U.Prospective Diabetes Study Group 1993: UK prospective diabetes study IX Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 diabetes mellitus and after 3 months diet therapy. Diabetologia 36(9): 835-842

Atkins, W.S.; Edwards, R.; Cuzick, J.; Wardle, J.; Northover, J.M.A. 1998: UK randomized controlled trial of once only flexible sigmoidoscopy screening Interim results. Gastroenterology 114(4 Part 2): A560

Kehinde, E.O.; Terry, T.R.; Mistry, N.; Horsburgh, T.; Sandhu, D.P.; Bell, P.R. 1995: UK studies on suramin therapy in hormone resistant prostate cancer. Cancer Surveys 23: 217-229

Ueki, M.; Taniguchi, M. 1997: UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. III. Antibacterial action of demethyl UK-1. Journal of Antibiotics 50(9): 788-790

Ueki, M.; Shibata, K.; Taniguchi, M. 1998: UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. IV. Antifungal action of methyl UK-1. Journal of Antibiotics 51(9): 883-885

Moore, B.A.; Keir, R.F.; Stuart, E.F.; Stobie, A.; Wright, K.N. 1996: UK-112, 166 A novel muscarinic antagonist with selectivity over M-2 receptors. European Respiratory Journal Suppl 9(23): 30S

Wallis, R.M.; Alker, D.; Burges, R.A.; Cross, P.E.; Greengrass, P.M.; Mcintyre, P.; Quinn, P. 1994: UK-84149 A novel gut-selective spasmolytic with calcium antagonist activity. British Journal of Pharmacology 112(Proceedings Suppl ): 574P

Quinn, P.; Wallis, R.M. 1994: UK-84149 A potent and gut-selective spasmolytic in the anaesthetised dog. British Journal of Pharmacology 112(Proceedings Suppl ): 573P

Gingell, C.J.C.; Jardin, A.; Olsson, A.M.; Dinsmore, W.W.; Osterloh, I.H.; Kirkpatrick, J.; Cuddigan, M. 1996: UK-92, 480, a new oral treatment for erectile dysfunction A double-blind, placebo-controlled, once daily dose response study. Journal of Urology 155(5 Suppl): 495A

Eardley, I.; Morgan, R.J.; Dinsmore, W.W.; Pearson, J.; Wulff, M.B.; Boolell, M. 1996: UK-92,480, A new oral therapy for erectile dysfunction, a double-blind, placebo controlled trial with treatment taken as required. Journal of Urology 155(5 Suppl): 495A

Boolell, M.; Gepi Attee, S.; Gingell, C.; Allen, M. 1996: UK-92,480, a new oral treatment for erectile dysfunction A double-blind, placebo controlled crossover study demonstrating dose response with Rigi Scan and efficacy with outpatient diary. Journal of Urology 155(5 Suppl): 495A

Terrett, N.K.; Bell, A.S.; Brown, D.; Ellis, P. 1995: UK-92,480, a potent and selective inhibitor of type V-A CGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Abstracts of Papers American Chemical Society 210(1-2): MEDI 229

Axon, A.T. 1998: UK-Japan exchange programme: Japanese endoscopists in the general infirmary at Leeds. Japanese Journal of Clinical Oncology 28(9): 531-532

Barrett Lee, P.J.; Bliss, J.M.; Brown, J.; Brunt, M.; Cull, A.; Denton, S.; Earl, H.; George, D.; Gould, A.; Harnett, A.; Johnson, L.; Perren, T.; Raina, V.; Twentyman, P.; Yarnold, Y.R. 1996: UKCCCR Adjuvant Breast Cancer Trial. British Journal of Cancer 74(Suppl 28): 4

Houghton, J.; Meadow, H.; Lennon, T.; Northover, J.M.A. 1994: UKCCCR anal cancer trail. European Journal of Cancer 30A(Suppl 1): S29

Oakhill, A. 1994: UKCCSG studies of paediatric germ cell tumours. Jones, W G, Harnden, P, Appleyard, I Advances in the Biosciences; Germ cell tumours III 57-58

Laukkanen, R.M.T.; Elo, A.; Kukkonen Harjula, K.; Oja, P.; Uusi Rasi, K.; Vuori, I. 1995: UKK walk test as a measure of maximal aerobic power during walking training. Medicine and Science in Sports and Exercise 27(5 Suppl): S97

Cull, C.A.; Holman, R.R.; Turner, R.C. 1995: UKPDS 6 year trial of sulphonylurea, insulin and metformin therapy in type 2 diabetic patients with diet failure. Diabetologia 38(Suppl 1): A24

Widjaja, A.; Stratton, I.M.; Horn, R.; Holman, R.R.; Turner, R.C.; Brabant, G. 1996: UKPDS Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects. Diabetologia 39(Suppl 1): A144

Stratton, I.M.; Turner, R.C. 1995: UKPDSProgression of sub-clinical indices of tissue damage over 6 years from diagnosis of type 2 diabetes. Diabetologia 38(Suppl 1): A19

Johnson, R.; Belger, M.; Postlethwaite, R.J.; Rigden, S.P.A.; Verrier Jones, K. 1998: UKTSSA Paediatric Task Force report on factors affecting paediatric kidney tramolant survival. Pediatric Nephrology 12(7): C61

Ansel, G.; Coyne, K.; Arnold, S.; Mimer, J.; Nelson, S.D. 1992: UL-FS 49 prevents ventricular tachycardia induced by tricyclic antidepressant overdose. Clinical Research 40(3): 747A

Vos, M.A.; Leunissen, J.D.; Van Der Zande, J.; Wellens, H.J. 1994: UL-FS 49, a rather selective blocker of the pacemaker current I-f has no effect on automatic ventricular arrhythmias occurring 24 hours after infarction. Journal of the American College of Cardiology 1994(SPEC ISSUE): 183A

Villante Umberto; Lepidi Stefania; Francia Patrizia; Vellante Massimo; Meloni Antonio; Palangio Paolo 2000: ULF fluctuations at Terra Nova Bay Antarctica. Annali di Geofisica 43(2): 217-227

Obermayer, A.; Goestl, K. 2008: ULkus am FuBrucken verursacht durch eine intermetatarsale Perforansvene. Phlebologie 37(1): 17-19

Garcia Feijoo, J.; Cuina Sardina, R.; Benitez Del Castillo, J.M.; Arias Puente, A.; Andres, M.V.; Garcia Sanchez, J. 1997: UMB in anterior uveitis associated with ankylosing spondylitis. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S525

Scerbo, M.; Larson, M.; Sommers, W.R.; Rodriguez, S.; Herzog, W.R.; Gurbel, P.A.; Stafford, J.L.; Ziskind, A.A. 1993: UMCATH A data-driven catheterization laboratory database and clinical reporting system with a network graphical user interface. Journal of the American College of Cardiology 21(2 Suppl A): 13A

Byrne, D.E.; Mcgarrick, J.; Ward, J.P.T. 1997: UMDS respiratory system courseware A computer-aided learning package for medical and dental undergraduate teaching. Journal of Physiology (Cambridge) 505P: 2P

Banerjee, M.; Thompson, D.S.; Lazzell, A.; Carlisle, P.L.; Pierce, C.; Monteagudo, C.; López-Ribot, J.é L.; Kadosh, D. 2008: UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Molecular Biology of the Cell 19(4): 1354-1365

GabrielFilho,A.; Lancas,K.P.; Guerra,S.P.; Paula,C.A.; Monteiro,L.A. 2008: UMEB - mobile drawbar test unit. Engenharia Agricola: 4, 782-789

Trujillo, J.; Martiez, L.; Ochoa, R.; Ventura, J.; Valdivia, I.; Garcia, M.; Lazo, E.; Delahanty, A. 1995: UMELISA for the quantification of anti-HBsAG. Biotecnologia Aplicada 12(2): 100-101

Dec Bronsvoort, B.M.; Makepeace, B.L.; Renz, A.; Tanya, V.N.; Fleckenstein, L.; Ekale, D.; Trees, A.J. 2008: UMF-078: a modified flubendazole with potent macrofilaricidal activity against Onchocerca ochengi in African cattle. Parasites and Vectors 1(1): 18

Miller, D.A.; Herrington, S.M.; Higgins, J.C.; Schroeder, D.W. 1995: UMHW polyethylene in total joint replacement History and current technology. Wise, D L , Trantolo, D J , Altobelli, D E , Yaszemski, M J , Gresser, J D , Schwartz, E R Encyclopedic handbook of biomaterials and bioengineering, Part B: Applications, Vols 1 and 2 665-688